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The mitochondrial respiratory chain (MRC) plays a crucial role in cellular energy 
production, which is needed for cell division, movement, secretion, and activation of 
signaling pathways. MRC mutations cause diseases with multi-system disorders 
including encephalopathies, myopathies and cardiomyopathies,  which occur in 1 per 
10,000 live births in humans (Triepels et al., 2001). Depletion of MRC activity results in 
severe abnormalities in embryo development  and leads to embryonic lethality (Huang et 
al., 2004; Larsson et al., 1998).  The lack of an adequate animal model imposes limits on 
our current understanding of molecular processes in MRC-dependent embryonic 
development and the pathogenesis of these MRC diseases. To address this issue, GRIM-
19, a newly identified MRC complex I subunit, was knocked down in Xenopus embryos. 
The embryos exhibited typical phenotypes associated with mitochondrial diseases 
including retarded growth, mitochondrial proliferation, and moderately serious levels of 
neural, eye, and muscle tissue disorders. However, the most striking phenotype exhibited 
is that of defective heart formation. This can be rescued by reintroduction of human 
GRIM-19 mRNA. The heart tube failed to loop in most of GRIM19 knocked-down 
embryos, and the expression of several cardiac markers such as Nkx2.5 and its 
downstream gene, MLC2, and cardiac actin, were also reduced. Upon further 
investigation, we found that the activity of NFAT, a family of transcription factors that 
contributes to early organ development, was down-regulated in GRIM-19 knockdown 
embryos. Furthermore, expression of a constitutively active form of mouse NFATc4 in 
these embryos could restore normal heart development. NFAT activity is controlled by 
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the calcium-dependent phosphatase protein, calcineurin, which suggests that calcium 
signaling may be disrupted by GRIM-19 knockdown. Indeed, both the calcium response 
and calcium-induced NFAT activity were impaired in cell lines of knocked-down GRIM-
19, and NDUFS3, another complex I subunit. We also showed that NFAT can rescue 
expression of Nkx2.5 in GRIM-19 knocked-down embryos; NFAT binds on directly 
Nkx2.5 promoter and up-regulates Nkx2.5 transcription. Our data demonstrates the 
essential role of the MRC in heart formation and sheds light on the signal transduction 
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1.1. Mitochondrion respiratory chain (MRC)  
  Cells need energy to move, contract, divide and produce secretary products to 
communicate with other cells. The primary energy currency inside cells is adenosine 
triphosphate (ATP), a high energy phosphate nucleotide.  Hydrolysis of ATP releases 
energy, which meets the need of various biological reactions in cells. ATP is 
manufactured by several cellular process including glycolysis, photosynthesis and 
oxidative phosphorylation. The majority of ATP production in eukaryotic cells is fulfilled 
by oxidative phosphorylation in mitochondria. Mitochondria are believed to have evolved 
from aerobic bacteria which colonized primordial eukaryotic cells that lacked aerobic 
metabolism (Wallace, 2005). Mitochondria endowed eukaryotic cells with the ability to 
produce ATP by oxidative phosphorylation, a much more efficient way to generate energy 
than through anaerobic glycolysis. The Mitochondrion is a double membrane bound 
organelle in eukaryotic cells. It contains four compartments: the outer membrane which 
encloses the organelle, the inner membrane which folds inside forming shelve-like 
structures called “cristae”, the inner membrane space, and the matrix which is localized 
inside the inner membrane. Oxidative phosphorylation and ATP synthesis are performed 
by the mitochondrial respiratory chain (MRC) located on the inner membrane of the 
mitochondria. 
 
1.1.1. Oxidative phosphorylation.  
  Oxidative phosphorylation is the main source of generating ATP in cells. The 
energy of cells comes from oxidation of fuel molecules such as lipids and carbohydrates, 
especially glucose. Three biochemical reaction steps are needed to convert energy from 
                                                                                                                               Chapter 1  
                                                                                                                                             3 
these energy-containing molecules into ATP. In the first step, glucose or fatty acids are 
broken-down and converted to acetyl CoA (acetyl coenzyme A) and carbon dioxide. The 
energy released from these processes is used to generate ATP as well as NADH and 
FADH2. The breakdown of glucose in this step is termed glycolysis, in which glucose is 
broken down into two three-carbon molecules known as pyruvate. Glycolysis yields two 
pyruvate molecules, and a net gain of 2 ATP and two NADH per glucose. The overall 
reaction is: 
1 Glucose + 2 NAD+ + 2 Pi + 2 ADP → 2 pyruvate + 2 NADH + 2 ATP + 2 H2O  
  In the absence of oxygen, pyruvate is not metabolized via aerobic respiration but 
converted to waste products such as lactate in the cytoplasm. However, in the presence of 
oxygen, pyruvate translocates to the matrix of mitochondria where it is converted to acetyl 
CoA and proceeds to the next step, the citric-acid cycle (also named Krebs cycle). During 
this process, the acetyl CoA is further broken down into carbon dioxide and releases the 
energy to generate ATP, NADH and FADH2. The net energy gain in the citric acid is 
1ATP, 3 NADH, and 1 FADH2 per acetyl CoA. The overall reaction is: 
acetyl CoA + 3 NAD+ + FAD + ADP + 2 Pi   2 CO2 +3 NADH + 3 H+ + FADH2 + ATP 
  Thus, only limited energy from the breakdown of glucose is used for generation of 
ATP during glycolysis and citric-acid cycle. The majority of energy is transfered to 
NADH and FADH2 which are used to produce ATP by the third process termed oxidative 
phosphorylation. Oxidative phosphorylation is the process in which ATP is formed as a 
result of the transfer of electrons from NADH and FADH2 to O2 by protein complexes of 
the mitochondria respiratory chain within mitochondria inner membrane. During this 
process, protons are pumped from the mitochondrial matrix into the intermembrane space 
to generate a transmembrane proton potential as a result of electron flow. The protons then 
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flow back to the matrix via ATP synthase on the inner membrane where the proton 
potential energy is used to produce ATP.  A total of 10 protons are ejected to the 
intermembrane space for every 2 electrons which are transferred from NADH to oxygen. 
Oxidation of FADH2 also transfers 6 protons from the matrix to the intermembrane space. 
Production of 1 ATP requires 4 protons flowing back to the matrix. Thus each NADH 
molecule contributes enough proton motive force to generate 2.5 ATP. Each FADH2 
molecule generates 1.5 ATP. Altogether, through oxidation of one glucose molecule, the 8 
NADH and 2 FADH2 molecules account for production of more than 23 ATP by oxidative 
phosphorylation. The total ATP production from aerobically metabolized glucose is 
around 30 ATP in comparison with to the 2 from anaerobic glycolysis. Therefore, aerobic 
respiration is approximately 15 times more efficient than anaerobic.  
 
1.1.2. Components of mitochondrial respiratory chain MRC 
  The mitochondrial respiratory chain (MRC) catalyzes oxidative phosphorylation 
which plays a crucial role in aerobic respiration of cells. The MRC consists of five multi-
subunit complexes (complexes I-V) and two additional electron carriers: coenzyme Q10 
and cytochrome c. MRC complexes I-IV, coenzyme Q10 and cytochrome c act as electron 
carriers which transfer two electrons from reducing substrates (NADH and FADH2) to 
molecular oxygen. Thus the electron carriers are said to form an electron-transport chain.  
MRC complexes I, III and IV are also proton pumps which simultaneously pump protons 
from the matrix to the intermembrane space to generate a proton gradient across the inner 
mitochondrial membrane. The electrochemical energy of this gradient is then used to drive 
ATP synthesis by complex V.  An overview of morphology and function of MRC is 
illustrated in Figure 1.1.  
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                                                                      Adopted from electron transport chain lecture by Antony Crofts  
 
Figure 1.1. Schematic of morphology and function of MRC. 
 
1.1.2.1.  NADH:ubiquinone oxidoreductase (Complex I) 
  NADH:ubiquinone oxidoreductase (complex I) of the MRC catalyzes the first step 
of electron transfer. It catalyzes the oxidation of NADH, the reduction of ubiquinone, and 
the transfer of 4H+ across the mitochondrial inner membrane. Complex1 is the largest 
complex composed of at least 46 structural subunits in humans. Among them, 7 subunits 
are encoded by mitochondrial DNA (mtDNA), while others are encoded by nuclear DNA 
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complex domains.  The peripheral domain corresponding to the “ankle” of the boot 
protrudes from the mitochondrial inner membrane to the matrix. The inner membrane 
domain (the “foot” of boot) contains hydrophobic proteins and is bounded in the inner 
membrane. Electron transfer starts from the peripheral domain of complex 1 where NADH 
is oxidized and 2 electrons are transferred to Flavin MonoNucleotide (FMN). The 
electrons are then passed to the iron-sulfur centers which are also located in the 
hydrophilic peripheral domain. Through the iron-sulfur centers, the electrons are finally 
transferred to ubiquinone (also named coenzyme Q, CoQ or Q) which is close to the 
interface between the peripheral and intra-membrane domains. Simultaneously, 
ubiquinone (Q) takes up two protons from the matrix side, to form fully reduced ubiquinol 
(QH2). The hydrophobic ubiquinol feeds into a ubiquinone pool inside the inner 
membrane and diffuses to complex III. Complex I produce 1 QH2, per NADH oxidized. 
During the process of electron transfer from NADH to ubiqinone, complex I pumps 4 
protons across the coupling membrane to generate an inner membrane proton potential. 
The total reaction of complex1 can be described as: 
NADH + H+ + Q + 4H+N <==> NAD+ + QH2 + 4H+P   
In this chapter, N means N-side (the protochemically negative matrix side). P means P-side 
(the protochemically positive inter-membrane-space side of mitochondrial inner 
membrane).   
 
1.1.2.2.  Succinate:ubiquinone oxidoreductase ( Complex II) 
  FADH2 is oxidized by succinate:ubiquinone oxidoreductase (complex II). 
Complex II is the smallest complex, containing only 4 nuclear coded proteins. The 
complex II is an important enzyme complex in both the citric-acid cycle and the 
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mitochondrial respiratory chain. During the citric-acid cycle, complex II oxidizes 
succinate to fumarate. The electrons from succinate are accepted by FAD which is 
subsequently reduced to FADH2 during oxidation of succinate to fumarate. FADH2 is then 
reoxidized by electron transfer through a series of three iron-sulfur centrers of complex II 
to ubiquinone, yielding QH2. The energy released from oxidation of succinate and FADH2 
is inadequate to pump H+. Therefore, this complex only generates one QH2 per succinate 
oxidized and pumps no protons across the inner membrane. The total reaction of complex 
II can be described as:   
succinate + Q <==> fumarate + QH2 
  Both complex I and complex II transfer electrons to ubiquinone which then ferries 
the electrons to complex III. Ubiquinone is the only non-protein electron carrier of the 
mitochondrial respiratory chain. It is very hydrophobic and dissolves within the lipid core 
of the inner membrane. The quinine ring of ubiquinone accepts 2 electrons and is reduced 
to ubiquinol (QH2). Ubiquinone can also accept a single electron to generate 
ubisemiquinone radicals (QH·). QH· can be very dangerous as they generate superoxide 
radicals (O2.-). O2.-  has  limited reactivity with lipids. However, O2.-  can be dismutated to 
H2O2 . The H2O2 will undergo the fenton reaction to form hydroxyl radicals( OH·) which 
is  far more reactive and lethally destructive than O2.- . In order to cope with these free 
oxygen radicals, mitochondria contain superoxide dismutase and glutathione peroxidase 
(GSH) to reduce free oxygen radicals to H2O.  
 
1.1.2.3. Ubiquinol:cytochrome c oxidoreductase (Complex III) 
  Complex III accepts the electrons from ubiquinol (QH2),  passes the electrons to 
cytochrome c (cyt c) and transports protons across the inner membrane from the matrix 
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site to the inter membrane space. The oxidation of every QH2 produces 2 cyt cred (reduced 
cytochrome c) and pumps 4 proton. Human complex III contains 11 subunits. Among the 
subunits, only cytochome b (cyt b) is encoded by mtDNA. The process in which complex 
III transfers electron from the two-electron-carrying QH2 to the single-electron carrying 
cyt c is catalyzed by three subunits: cyt b, cyt c1 and an iron sulfur protein through a two-
step Q cycle. In the first step, one QH2 gives up its two electrons to complex III. One 
electron passes through the iron sulfur protein and cyt c1 to the oxidized cyt c (cyt cox ) to 
form cyt-cred. The other electron is carried through two cyto-b centres and delivered to 
ubiqinone to form a semiquinone (QH·). Once QH2 is oxidized, it releases its two H+ to 
the inter membrane space. The same process happens again with another QH2. The second 
QH2 contributes its two electrons to produce one more cyt cred and fully reduces the QH· 
to QH2. Again, it pumps two H+ into the intermembrane space.  Thus the Q cycle 
consumes two QH2, but generates only one in return. In the whole process, there is a net 
oxidation of just one QH2 and reduction of two cyt c, and 4 H+ ions are pumped across the 
inner membrane. The total reaction of complex III can be described as: 
QH2 + 2 cyt-cox + 2H+N <==> Q + 2 cyt-cred + 4H+P 
  Cytochrome c is a small, water soluble protein which transfers electrons from 
complex III to complex IV.  It is among the three types (a,b,c) of  cytochromes containing 
a heme group. Cytochrome c contains a heme-c prosthetic group. The Fe ion in the heme 
group can either be in the oxidized (Fe3+) or the reduced (Fe2+) form. This makes the Fe 
ion of cyt c severe as an electron carrier for transfer of electrons between complex III and 
complex IV.  Besides being an essential component of the electron transfer chain, cyt c is 
also an intermediary in apoptosis. Pro-apoptotic stimuli can trigger the release of cyt c 
from mitochondria into cytosol where it activates a caspase cascade. The caspases are 
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cysteine proteases which carry out the cleaving of both structural and functional elements 
of the cell, resulting in cell death.  
 
1.1.2.4. Cytochrome c oxidase (Complex IV) 
  Cyt c transfers the electron to the last complex of mitochondrial electron 
transportation chain, complex IV (cytochrome c oxidase). Complex IV catalyses the 
oxidation of cyt c and passes the electron from cyt c to O2 to generate H2O. The enzyme is 
responsible for over 90% of oxygen consumption in aerobic organisms. Human complex 
IV contains 10 nuclear-coded subunits and 3 mitochondrial DNA-coded subunits. The 
mitochondia-synthesized subunits I and II are the catalytic subunits which contain two 
cytochromes, the a and a3 cytochromes, and two Cu centres (the CuA centre and CuB 
centre). The electron of cyt c is transferred to the CuA centre first, then moves to 
cytochrome a and next to cytochrome a3 which is coupled to CuB. Cytochrome a3 and CuB 
form a binuclear center where O2 is reducted to H2O. During this process, complex IV 
pumps 1 H+ out of the inner membrane per cyt c oxidized. The total reaction of complex 
IV can be described as:   
4 cyt-cred + O2 + 8H+N 4 cyt cox + 2H2O + 4H+P 
 
 
1.1.2.5.  ATP synthase (Complex V) 
  The mitochondrial electron transport chain (complexes I to IV) generates a proton 
gradient across the mitochondrial inner membrane, which is used for ATP production by 
ATP synthase (complex V). This enzyme is highly conserved through evolution and has 
been well studied. The human complex V contains around 16 subunits (2 of them are 
encoded by mtDNA) which make up two portions of this enzyme complex. The F1 portion 
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is a soluble ATPase localized in the matrix side of inner membrane. It is connected to F0 
portion which is embedded in the inner membrane and serves as a proton channel. The 
proton potential across the inner membrane drives the proton through the membrane via   
the F0 portion of complex V.  As protons flow through F0, they force the ring of c-subunits 
to rotate. This rotation is transmitted to the F1, which causes catalytic nucleotide binding 
sites to go through conformational changes that make ADP and phosphate react to form 
ATP. To generate 1 ATP, 3 protons flow through the inner membrane. Under certain 
conditions, the enzyme reaction of complex V can also be carried out in reverse, with ATP 
hydrolysis driving proton pumping across the membrane.  The total reaction of complex V 
can be described as:   
ADP + Pi + 3H+P <=> ATP + 3H+N 
  In summary, the mitochondrial respiratory chain contains 5 multisubunit 
complexes which produce ATP through oxidative phosphorylation. Since ATP production 
is so important for various biological processes in cells, it is not surprising that mutation 
of subunits of MRC complexes causes severe multi-system disorders in human beings.   
   
1.1.3. MRC diseases 
  Mitochondrial respiratory chain  disorders occur in 1 per 10,000 live births in 
humans (Triepels et al., 2001).   Since the transcription of MRC subunits is under control 
of two genomes, in the mitochondrial DNA (mtDNA) and nuclear DNA (nDNA), MRC 
diseases can be caused by mutaion of either mtDNA or nDNA. The mitochondrial DNA is 
a 16,569-bp circular double-stranded DNA containing genes coding for 2 ribosomal 
RNAs, 22 transfer RNAs, and 13 proteins. All of 13 proteins are subunits of various MRC 
complexes. The mtDNA is easily damaged. The mutation rate of mtDNA is about ten 
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times greater than that of nuclear DNA, which possibly due to the following reasons: 
firstly, mtDNA is prone to exposure to free oxygen radicals which are byproducts of 
oxidative phosphorylation. Secondly, the mitochondria lack DNA repair mechanisms to 
fix the mtDNA damage.  Over 100 mutations affecting both mitochondrial tRNA and 
mtDNA-coded MRC subunits have been identified. However, the mtDNA mutation does 
not affect all the mitochondria in the cells. Mitochondria within the same cell can have 
different variations of the mtDNA genome, which is inherited from mutiple mtDNAs of 
the mother's ovum. Furthermore, different mtDNA are randomly distributed into daughter 
cells during cell division. Thus the offspring may have various ratios of mutant versus 
wild-type mitochondria in the cells.  The ratio varies from person to person and tissue to 
tissue (depending on its specific energy, oxygen, and metabolism requirements, and the 
effects of the specific mutation). When the ratio of mutant versus wild-type mitochondria 
reaches threshold levels in certain tissues, it will lead to MRC diseases. MRC diseases 
caused by mtDNA mutation can be very different. Some are found at or even before birth 
whereas others do not show themselves until late adulthood. Mitochondrial MRC diseases 
often affect high energy-expenditure systems such as the central nervous system (CNS), 
the skeletal muscles and the heart. It can cause encephalopathy, aural or visual loss, 
hypotonia, myopathy with exercise intolerance, and cardiomyopathy. Leigh syndrome is 
one of the common clinical syndromes of mitochondrial MRC diseases. It was first 
described by Denis Leigh in 1951 (LEIGH, 1951). Leigh syndrome usually occurs 
between ages of three months and two years. The disorder worsens rapidly; the first signs 
may be loss of head control and poor sucking ability. As the disorder becomes worse, 
other symptoms such as heart problems, lack of muscle tone (hypotonia), and generalized 
weakness may develop. Nearly all the patients exhibit developmental delay and lactic 
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acidosis, a condition by which the body produces too much lactic acid. In rare cases, 
Leigh syndrome may begin late in adolescence or early adulthood, and in these cases, the 
progression of the disease is slower than the classical form. MRI image in these patients 
usually shows bilaterally symmetrical abnormalities in the brain stem, cerebellum and 
basal ganglia. Muscle biopsy often reveals characteristic mitochondrial proliferation and 
COX negative ragged red fibers in skeletal muscle of the patients.   
  Beside the mtDNA mutations, nDNA mutations are also a common cause of MRC 
diseases.  For example, only 5-10% of complex 1 deficiencies can be linked to mutations 
in mtDNA, indicating that the main causes lie with genes encoded in nDNA (Triepels et 
al., 2001). nDNA mutations affect all mitochondria in the cells and results in a more 
severe MRC diseases than in those caused by mtDNA mutations. nDNA mutations mainly 
affect subunits in complex I and sometimes complex II, but are hardly found in complexes 
III to V (Sue and Schon, 2000).  This may be due to the fact that both complex 1 and II 
reduce ubiquinone in parallel, and the organism may be able to deal with the loss of either 
complex through the compensatory action of the other. Complex III to V are arranged in 
series downstream of the respiratory chain, mutations in which may cause lethality.  The 
complex I diseases with nDNA mutations are usually present at birth or in early childhood, 
and cause majority of patients die before the age of 5 years with a multisystem disorders, 
usually Leigh syndrome or Leigh-like syndrome (Smeitink and van den, 1999). 40-50% of 
the Leigh syndromes are associated with cardiomyopathy which exhibits a hypertrophic or 
dilated heart (Morris et al., 1996; Rahman et al., 1996).  Hepatopathy, renal tubulopathy 
and cataracts are also present in some complex I deficiency patients at lower frequencies 
(Kirby et al., 1999; Robinson, 1998).  
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  How complex I deficiencies cause the multi-systemic disorders remains largely 
unknown. Lack of an animal model limits our understanding of the pathogenesis of these 
MRC diseases. It has been reported that a knock out (KO) mice with an nDNA defect of 
the adenine nucleotide translocator 1 (ANT 1) exhibit typical phenotypes of human MRC 
diseases including cardiomyopathy, ragged red fiber, and mitochondrial proliferation 
(Graham et al., 1997).  However, the ANT1 defect can not completely account for the 
MRC defect since ANT1 only affects the translocation of ATP across the inner membrane. 
Thus ANT1 KO can only mimic the MRC mutation in lose of ATP production but not in 
other functional deficiencies such as loss of membrane potential and changes in ROS 
production. Another animal model comes from mitochondrial transcription factor A 
(TFAM)-deficient mice. TFAM is an nDNA-encoded high–mobility group (HMG)-box 
protein, which binds on the mtDNA promoter and promotes the expression of all 13 
mtDNA-encoded MRC subunits. TFAM+/- mice exhibit reduced mtDNA copy numbers 
and MRC deficiencies in the heart, while complete depletion of TFAM in mice 
compromises heart development and results in lethality around embryonic day 10.5 when 
circulation is essential for life (Larsson et al., 1998).  This raises the possibility that the 
MRC may be involved in embryonic development, especially cardiogenesis.  Since TFAM 
deficiency affects all mtDNA encoded MRC subunits, an animal model to study complex I 
diseases caused by deficiency of a single nuclear encoded subunit is needed. The only 
available animal model that suits this purpose comes from mice with a depletion in a 
nuclear encode complex I subunit, GRIM-19. 
1.1.4. GRIM-19 - a subunit of MRC complex I 
  GRIM-19 (Genes associated with Retinoid-IFN-induced Mortality-19) was 
originally identified as a nuclear protein related to interferon-β (IFN-β) and retinoic acid 
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(RA)-induced cell death in human cancer cell lines (Angell et al., 2000). Over-expressed 
GRIM-19 promoted apoptosis in these cells.  Subsequently, the GRIM-19 protein was 
found to be tightly associated and co-purified with the mitochondrial NADH:ubiquinone 
oxidoreductase (complex I) (Fearnley et al., 2001), which suggests GRIM-19 may be a 
subunit of complex 1. Indeed, immunofluorescence staining using both mouse anti-human 
GRIM-19 and rabbit anti-mouse GRIM-19 antibodies shows that GRIM-19 protein is 
primarily localized in mitochondria.  To reveal its physiological function, GRIM-19 was 
knocked out in mice by our laboratory. Complete ablation of GRIM-19 in mice causes 
early embryonic lethality before embryonic day 9.5 (Huang et al., 2004). The GRIM-19-/- 
failed to undergo gastrulation, suggesting a crucial role of GRIM-19 in early embryonic 
development. Although the embryonic lethality prevents the complete understanding of 
the GRIM-19 role in early embryo development, the blastocysts of GRIM-19-/- mice 
exhibited a compromised complex I assembly and enzymatic activity (Huang et al., 2004). 
These data indicate that GRIM-19 codes for a new subunit of mitochondrial complex I. 
GRIM-19 was subsequently renamed NDUFA13 by the HUGO Gene Nomenclature 
Committee (HGNC).  
  GRIM-19’s function acts as a complex 1 subunit is not in conflict with its role in 
INF-β- and RA-induced apoptosis. Actually, besides GRIM-19, other subunits of MRC 
also involved in INF-β and RA induced apoptosis such as NDUFS3, and NDUFS5 (Huang 
et al., 2006). Furthermore, depletion of GRIM-19 or NDUFS3 in cells prevented the 
apoptosis triggered by INF-β and RA induction (Huang et al., 2006). These data indicate a 
novel function of MRC in regulating apoptosis.  
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  Indeed, recent studies have broadened our understanding of MRC as an energy 
producer. Mitochondria and MRC have been found to play important roles in diverse 
biological processes including regulation of specific gene transcription through ‘retrograde 
communication’. This retrograde communication can act as a sensor of mitochondrial 
function that initiates readjustments of carbohydrate and nitrogen metabolism (Butow and 
Avadhani, 2004). For example, yeast cells lacking mtDNA exhibit upregulation of the 
CIT2 gene encoding peroxisomal citrate synthase (Liao et al., 1991). In mammalian cells, 
MRC dysfunction also can trigger specific gene expression such as CREB and CamK IV 
through altered Ca2+ dynamics (Arnould et al., 2002; Biswas et al., 1999). The role of 
MRC in regulation of Ca2+ dynamics will be discussed in the next section. In a summary, 
besides energy production, MRC may also affect distinct signaling pathways which 
regulated diverse biological processes from metabolism to calcium signaling. Studying the 
role of MRC in cell signaling will help us to understand the molecular mechanism of 
MRC diseases and the role of MRC in embryonic development.  
 
 1.2. Intracellular calcium signaling  
  In most cells, Ca2+ functions as an intracellular messenger to regulate various 
signaling pathways and gene expression (Carafoli, 2002; Berridge et al., 2003). The 
cytoplasm of resting cells has an Ca2+ concentration of 100 nM which is much lower than 
those in the endoplasmic reticulum (ER) and sarcoplasmic reticulum (SR) of cells 
(~100µM) or extracellular space (1 mM).  The intracellular Ca2+ concentration can rise to 
500-1000 nM through Ca2+ release from ER/SR or Ca2+ influx through the plasma 
membrane via specific Ca2+ channels. Opening of individual intracellular Ca2+ channels 
results in a transient and low level of Ca2+ release around the channel, termed as ‘quark’ or 
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‘blip’. However, these elementary events are rare and more commonly seen is a larger, 
coordinated opening of clusters of Ca2+ channels, known as puffs or sparks. The amplitude 
and duration of these sparks varies with the numbers of channels that open within each 
cluster upon stimulation. When the stimulation is strong enough, a high level of Ca2+ 
release from certain channel groups can excite neighbouring Ca2+ channels through a 
process of Ca2+ induced Ca2+ release (CICR), thereby setting up a regenerative Ca2+ wave. 
These intracellular Ca2+ waves can even spread to neighbouring cells via gap junctions to 
create intercellular waves. These diverse Ca2+ patterns control different biological 
processes. For example, intercellular Ca2+ waves in lung epithelia stimulate the beating 
frequency of cilia to clear mucous or particles from airway, while local Ca2+ pulses in the 
ends of synapses trigger release of neurotransmitters. Ca2+ signalling varies both spatially 
and temporally. Increases in [Ca2+]i are often observed not only in single Ca2+  pulses, but 
also as repetitive Ca2+ spikes or oscillations. The frequency of Ca2+ oscillations determines 
Ca2+ dependent enzyme activity such as CamkII and Ca2+-sensitive mitochondrial 
dehydrogenases (CSMDHs) (De Koninck and Schulman, 1998; Hajnoczky et al., 1995b), 
and controls the efficiency of gene expression through  NFAT and NF B pathway 
(Dolmetsch et al., 1998). Since the spatiotemporal organization of Ca2+ signalling is 
crucial for specific activation of diverse biological processes, it has to be precisely 
regulated to meet the different demands of these Ca2+-sensitive processes.  
 
             1.2.1 Regulation of calcium mobilization 
       The intracellular Ca2+ concentration is regulated by simultaneous interplay of multiple 
counteracting processes, which can be divided into Ca2+ ON and OFF mechanisms, 
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depending on whether they serve to increase or decrease cytosolic Ca2+. A schematic of 
Ca2+ ON and OFF mechanisms is presented in Figure 1.2. 
  
 
Figure 1.2. Regulation of calcium dynamics and homeostasis.  
 
1.2.1.1. Calcium ON mechanism 
  In general, mechanisms involved in the increase of cytosolic Ca2+ include 
regulation of channels located at the plasma membrane (PM) that regulate Ca2+ entry from 
(2003, 4: 517)
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the extracellular space and channels on the ER and SR which release pre-stored Ca2+ from 
the ER/SR into the cytosol.  
  The channels which control Ca2+ entry into the cells include voltage-opened Ca2+ 
channels (VOCCs), receptor-operated Ca2+ channels (ROCCs), and Ca2+ release-activated 
Ca2+ channels (CRACs). VOCCs are activated by depolarisation of PM and are found 
mainly in excitable cells such as neurons and muscle cells. The ROCCs are particularly 
prevalent on secretory cells and at synapses of neurons, where they are activated by a wide 
variety of agonists such as glutamate, ATP, serotonin and acetylcholine. The CRACs are 
activated in response to depletion of intracellular Ca2+ stores (Putney, Jr. and Bird, 1993), 
which links intracellular Ca2+ release with Ca2+ entry from the PM. CRACs are probably 
one of the most ubiquitous PM Ca2+ channels since many different cells exhibit an 
enhanced Ca2+ entry following intracellular Ca2+ store depletion. This enhanced Ca2+ entry 
is crucial in triggering Ca2+-dependent gene expression, thereby regulating the cell 
proliferation and differentiation.  
  The intracellular Ca2+ release is mediated by several messenger-activated channels 
such as InsP3 receptors (InsP3Rs) and ryanodine receptors (RyRs). Binding of stimulation 
factors ( such as growth factor, Wnt proteins) to their specific receptors on the PM leads to 
activation of phospholipase C (PLC) which catalyzes production of inositol 1,4,5-
triphosphate (InsP3), an important second messenger in cells. InsP3 is highly mobile in the 
cytosol and subsequently diffuses from PM to ER/SR membrane where it binds to its 
receptors (InsP3Rs). InsP3Rs are large ER/SR transmembrane proteins containing four 
subunits and an integral Ca2+ channel. Binding of InsP3 changes the conformation of 
InsP3Rs, triggering the opening of Ca2+ channels to allow release of Ca2+ from ER/SR-
stores to the cytoplasm. InsP3Rs activity is also regulated by Ca2+ concentrations. Modest 
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increases of cytosolic Ca2+ (0.1-0.3µM) enhances InsP3Rs opening, whereas higher 
cytosolic Ca2+ (>0.3µM) inhibits the opening of InsP3Rs. Thus, during the onset of 
InsP3Rs opening, the release of Ca2+ increases the sensitivity of InsP3Rs, resulting in a 
rapid rise in Ca2+ levels. Once the Ca2+ levels reach a certain amount, they inhibit InsP3Rs 
and prevent overloading of Ca2+ in the cytoplasm. In addition to these cytosolic functions, 
Ca2+ can also sensitize the InsP3Rs from the lumen of ER/SR. Decreasing [Ca2+]ER 
inactivates InsP3Rs, while overexpression of SERCA2b, a ER Ca2+ ATPases,  in Xenopus 
oocytes, elevated [Ca2+]ER and increased the amplitude of InsP3Rs-triggered Ca2+ 
oscillations (Caroppo et al., 2003).  ERp44, an ER lumenal protein of the thioredoxin 
family, has recently been found to directly interact with and regulate the activity of InsP3R 
type 1 in response to [Ca2+] ER (Gyorke et al., 2004; Higo et al., 2005). Another small 
molecule which regulates the opening of InsP3Rs is ATP. The presence of  ATP alone is 
not sufficient to open InsP3-gated channels, but in the presence of InsP3,  ATP or its 
nonhydrolyzable analogs increase the frequency of channel openings 4.8-fold and increase 
the average duration of channel openings 2.5-fold (Bezprozvanny and Ehrlich, 1993). In 
contrast , high concentrations of ATP (> 4 mM) decrease the channel activity, most 
probably by competing for InsP3-binding sites (Bezprozvanny and Ehrlich, 1993).  
Ryanodine receptors (RyRs) are located primarily in sarcoplasmic reticulum of 
excitable cells, unlike ubiquitously expressed InsP3Rs. The structures and functions of 
RyRs are similar to those of InsP3Rs. RyRs are also sensitive to the biophasic effects of 
Ca2+, although they are generally activated or inhibited by higher Ca2+ concentrations 
(activation at 1-10 µM and inhibition at >10 µM). This character allows RyRs to be 
stimulated by cytoslolic Ca2+ via calcium-induced calcium release (CICR) and respond to 
the muscle contraction and neuron excitation.  
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1.2.1.2.Calcium OFF mechanism 
         The Ca2+ OFF mechanisms include various Ca2+ puffers as well as pumps and 
exchangers which rapidly remove Ca2+ from cytosol. Ca2+ can either be extruded to the 
extracellular fluid by Ca2+ ATPases (PMCA) and the Na+/Ca2+ exchanger (NCX) on the 
PM, or returned to the ER/SR by sarco-endoplasmic reticulum ATPases (SERCAs) 
(Berridge et al., 2003). As Ca2+-ATPase, SERCA transports two Ca2+ ions against their 
concentration gradient, from the cytoplasm into ER lumen with the hydrolysis of one ATP 
molecule. These Ca2+ pumps are so important in regulating Ca2+ mobilization that they 
makes up 90% of membrane proteins in the sarcoplasmic reticulum (SR) of skeletal 
muscle. The function of SERCAs seems to couple with mitochondrial ATP synthesis. As 
shown in Figure 1.3, mitochondria are in close contact with the ER, which exposes them 
to higher concentrations of Ca2+ than the rest of the cytosol during activation of ER Ca2+ 
channels (Rizzuto et al., 1998). Once Ca2+ enters into mitochondria, it activates several 
dehydrogenases in the Krebs cycle, thereby increasing the levels of NADH and the 
production of ATP(Hajnoczky et al., 1995a; McCormack and Denton, 1993). The local 
ATP products are then consumed by SERCA on neighboring ER to resequester cytosolic 
calcium. This tight coupling of ATP supply and demand in Ca2+ signaling is supported by 
Dumollard’s work in the mice during fertilization, when the sperm triggers Ca2+ 
oscillations in the egg. In that study, oscillations of NAD++ and FAD++ (the OXPHOS 
products from complex I and II respectively) were observed in the egg. The oscillation 
frequency of NAD++ and FAD++  matched that of Ca2+ (Dumollard et al., 2004).  Inhibition 
of Ca2+ oscillations using the Ca2+ chelator BAPTA abolished the oscillations of FAD++. 
On the other hand, inhibition of OXPHOS by MRC inhibitors compromised sperm-
triggered Ca2+ oscillations. The MRC inhibitors also cause Ca2+ to leak from ER and 
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impair Ca2+ homeostasis probably by disrupting the ATP-dependent activity of SERCA 
(Dumollard et al., 2004). These data suggest that ATP production by MRC is crucial for 
maintenance Ca2+ homeostasis and oscillations in the egg.  In agreement with the finding 
in mouse egg, glucogon like peptide-1 has been shown to mobilize intracellular Ca2+  and 
stimulate mitochondria ATP synthesis in pancreatic MIN β-cells (Tsuboi et al., 2003). 
Furthermore, mitochondrial depolarization results in inhibition of InsP3- induced Ca2+ 
release in HeLa cells (Collins et al., 2000). Thus, the coupling of MRC ATP synthesis and 
intracellular Ca2+ mobilization may be a ubiquitous mechanism for regulation of Ca2+ 
signaling in organisms. 
         Mitochondria also function in Ca2+ regulation as a buffering system that can rapidly 
take up and slowly release large amounts of Ca2+ to shape both the amplitude and the 
spatio-temporal pattern of Ca2+ signal. The rapid Ca2+ up-taking is driven by mitochondria 
inner membrane potential through a uniporter that has a low sensitivity to Ca2+ (half-
maximal activation around 15 µM). Given the fact that mitochondria is in close contact 
with the ER Ca2+ channel resulting in high concentration of Ca2+ around the mitochondria, 
hence Ca2+ is still able to be transferred to the mitochondria matrix through the low 
sensitivity uniporter efficiently.  The Ca2+ buffer capability is important in protecting cells 
against cytosolic Ca2+ overloading under pathophysiological conditions (Duchen, 2000). 
The slow Ca2+ release in later stage also functions to extend the effect of Ca2+ dependent 
cellular processes.  Interestingly, mitochondrial Ca2+ buffering also help to shape Ca2+ 
release-activated Ca2+ current (ICRAC) through inhibition of Ca2+ dependent slow 
inactivation of Ca2+ influx (Parekh, 2003). The ATP production from subplasmalemmal 
mitochondria are reported to control this Ca2+-dependent inactivation of CRAC channels 
recently (Montalvo et al., 2006).  Thus, MRC plays a crucial role in controlling Ca2+ 
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mobilization through many ways from sequestering intracellular Ca2+ to modifying the 
activation of CRAC.  
         The off and on mechanisms are not mutual exclusive but are regulated by each 
other.  For example, intracellular calcium release will trigger the activity of SERCAs 
through boosting MRC ATP production. The SERCAs, in turn, help to sequester cytosolic 
Ca2+ and refill the ER Ca2+ store which is crucial for generating the Ca2+ release and 
oscillation. This delicately controlled Ca2+ signal regulates numerous cellular processes 
and signal pathways. In this study we focus on the effect of Ca2+ signal on one of it major 
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1.2.2. Calcium-calcineurin-NFAT signaling pathway  
  The Ca2+/calmodulin-dependent serine/threonine protein phosphatase, calcineurin, 
is one of the major targets controlled by Ca2+ and plays key roles in signaling pathways 
involved in antigen-dependent T-cell activation and embryo development (Crabtree and 
Olson, 2002). In both cases, calcineurin causes dephosphorylation of the cytoplasmic 
nuclear factor of activated T cells (NFAT) and drives the translocation of NFAT from the 
cytoplasm to the nucleus to regulate its downstream gene expression. An overview of 
calcium-calcineurine-NFAT signaling is illustrated in Figure 1.4. 
 












Figure 1.4. Calcium-Calcineurin-NFAT pathway.   
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1.2.2.1. Structure and function of calcineurin 
  Calcineurin (also named protein phosphatase 2B) is broadly distributed in different 
tissues and highly conserved among the species from yeast to human. The calcineurin 
holoenzyme consists of two subunits:  a ~60-kDa catalytic A subunit (CnA) and a 19 kDa 
regulatory B subunit (CnB)(Klee et al., 1998). The CnA subunit contains four functional 
domains: an N-terminal catalytic domain, a CnB-binding domain, a calmodulin (CaM)-
binding domain, and a C-terminal auto-inhibitory domain (Hubbard and Klee, 1989). The 
catalytic domain acts as a phosphatase and shares significant sequence homology with 
other phosphatases. However, the enzyme active site of the catalytic domain is blocked by 
the auto-inhibitory domain in the presence of low cytosolic Ca2+. The enzyme activity can 
be regulated via CnB-binding domain which tightly bounds to CnB through hydrophobic 
interactions (Watanabe et al., 1995; Watanabe et al., 1996). CnB has a structure similar to 
calmodulin. It has 1 high affinity and 3 low affinity Ca2+ binding sites.  Upon increase of  
intracellular Ca2+  to a certain level, it binds to the low-affinity sites of calcineurin B and 
affects the conformation change of both CnB and the regulatory domain of CnA, resulting 
in the exposure of the calmodulin-binding domain (Sikkink et al., 1995). The 
Ca2+/calmodulin then bind to the CaM-binding domain and causes further conformational 
changes. The conformation change in the flexible CaM-binding domain displaces the 
auto-inhibitory domain from the active site, thereby activating the phosphatase 
activity(Griffith et al., 1995; Kissinger et al., 1995; Klee et al., 1998). Calcineurin is the 
only serine/threonine protein phosphatase under the control of cytosolic Ca2+. Unlike other 
phosphatase which can be inhibited by okadaic acid, calyculin, and microcystin, 
calcineurin is resistant to those chemicals (Cohen et al., 1996; Shenolikar, 1994). 
However, the enzyme activity of calcineurin can be specific inhibited by two 
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immunosuppressive drugs, cyclosporin A (CsA) and FK506 (Shenolikar, 1994).  These 
two drugs provide a useful tool in revealing the function of calcineurin and its downstream 
targets (Klee et al., 1998; Liu et al., 1992).         
 
1.2.2.2. Structure and function of NFAT 
  The most well characterized target of calcineurin is the NFAT proteins. The NFAT 
family comprises four cytosolic proteins (NFATc1-4) and a constitutive nuclear 
phosphoprotein (NFAT5) (Crabtree and Olson, 2002; Horsley and Pavlath, 2002; Lopez-
Rodriguez et al., 1999). NFAT5 is the primordial family member which is the only one 
represented in the Drosophila genome(Lopez-Rodriguez et al., 2001). The function of 
NFAT5 is less clarified and the activity of NFAT5 is Ca2+-independent which defers from 
the well documented NFATc1-4 (Lopez-Rodriguez et al., 1999). Therefore, NFATs 
usually refer to the four Ca2+-dependent isoforms (NFATc1-4). All four NFAT proteins 
contain a conserved regulation domain and DNA binding domain. The regulation domain 
is heavily phosphorylated in the resting cells. As shown in Figure 1.5, a nuclear 
translocation signal (NLS) is localized among the heavily phosphorylated serine rich 
motifs (SRR-1, SPxx repeat, SRR-2 and KTS motifs) in the regulation domain (Hogan et 
al., 2003). Phosphorylation of those motifs blocks the access of NLS to nuclear import 
system, keeping the NFATs in the cytoplasm. Upon Ca2+  stimulation, the activated 
calcineurin can dock on the NFAT regulation domain and dephosphorylates those serine-
rich motifs, resulting in the expose of  NLS  and triggers the subsequent nuclear 
translocation and transcriptional activity (Crabtree and Olson, 2002). The calcineurin is 
also present in the nucleus of stimulated cell, where it maintains the dephosphorylated 
status and nuclear localization of NFAT. In absent of Ca2+ and calcineurin activity, the 
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NFAT is reposphorylated by NFAT kinase such as GSK3 and rapidly exported from the 
nucleus (t1/2 ~15 min) (Timmerman et al., 1996). 
 
                                                                                                    
Figure 1.5.  Schematic of NFAT domain (based on mouse NFATc2).   
 
  As a result of this absolute dependence on Ca2+/calcineurin signaling, NFAT 
activity is profoundly regulated by the dynamic changes in intracellular Ca2+ level. 
Binding of ligand to its receptor such as T cell receptor (TCR) results in activation of 
PLC, increases intracellular InsP3, and triggers Ca2+ release from intracellular storage. The 
Ca2+ release can form a signal spike or oscillated Ca2+ wave with different frequency. 
Single Ca2+ spike is not sufficient to activate NFAT probably due to the rapid export of 
NFAT from nucleus. It has been shown that  activation of NFAT requires a high 
frequency of Ca2+ spikes (Dolmetsch et al., 1998).  This high frequency of  Ca2+  release 
depletes the intracellular Ca2+ store and trigger the opening of Ca2+ release activated Ca2+ 
channel (CRAC) on plasma membrane. The opening of CRAC results in a prolonged Ca2+ 
entry which is crucial for activating NFAT. Mutant lymphocyte with CRAC deficiency 
fails to promote Ca2+ through CRAC channel, resulting in a rapid transient Ca2+ release 
from intracellular store. NFATs are not maintained in the nucleus of mutant cells, hence, 
are unable to activate NFAT-dependent transcription of immune response genes. Similar 
Genes & development 2003, 17:2205 
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CRAC defect also has been found in patients with severe combined immunodeficiency 
(SCID). The patients fail to activate NFAT regulating genes such as IL-2, IL4 and CD40 
ligand probably due to the compromising of the sustain Ca2+ signal (Le Deist et al., 1995) . 
The sustained Ca2+ activation pattern also counts for the regulatory specificity  of NFAT 
signaling since this mechanism prevent brief Ca2+ pulses, such as those involved in cell 
locomotion and adhesion, from activating NFAT- dependent genes (Crabtree, 1999). 
  Upon entering nucleus, NFAT proteins bind onto DNA through the Rel-homology 
DNA binding domain to regulate gene transcription (Hogan et al., 2003; Rao et al., 1997). 
The core NFAT binding element is 5’-GGAAA-3’ or 5’-TTTCC-3’(Hogan et al., 2003). 
However, NFAT may not bind DNA in vivo without assistance. It has been shown that 
Ca2+ signal has to be coincident with a PKC/MAP signal to activate NFAT dependent 
transcription. Further studies revealed that AP-1 transcription factor, a product of 
PKC/MAP signaling, cooperates with NFAT to bind on DNA and regulates expression of 
their downstream genes including IL-2, IL-4 and GM-CSF in lymphocytes. Several other 
transcription factors were also found to cooperate with NFAT and increase NFAT DNA 
binding affinity including GATA binding transcription factors (GATAs) and The MADS-
box transcription factor (MEF). It has been shown that interaction of NFAT with GATA is 
essential for regulation of cardiac genes expression such as b type natriuretic peptide 
(BNP), and MEF2 interacts with NFAT to mediate gene expression in both 
immunoresponse and controlling  skeletal muscle fiber type (Blaeser et al., 2000; Chin et 
al., 1998; Molkentin et al., 1998; Wu et al., 2000). The cooperation with those cell type 
specific cofactors, such as GATA and MEF, renders NFAT–dependent transcription a 
tissue specific pattern in response to the Ca2+ stimulation.  
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1.2.3 Role of NFAT in cardiogenesis 
  Different NFAT isoforms are considered to have redundant functions. However, 
the specific tissue distribution of individual NFAT protein makes NFATs possess different 
functions in a wide range of cells. NFATc1 and c2 are highly expressed in peripheral 
lymphoid tissues(Hoey et al., 1995; Park et al., 1996). NFATc1/c2 knockout mice fail to 
activate T cells , resulting in a deficiency of expressing NFAT dependent immune 
response genes (Peng et al., 2001). NFATc3 is expressed at high level in thymus. 
Disruption of NFATc3 results in defects in hyperproliferation of lymphocytes and thymic 
development (Masuda et al., 1995).  NFATc1, c2 and c3 also present in skeletal muscle 
where they are involved in regulation of myocyte hypotrophy and differentiation of slow 
skeletal muscle fibres (Musaro et al., 1999; Olson and Williams, 2000). NFAT activity is 
also involved in early embryo development. It has been found that a Wnt/Ca2+ pathway 
triggers the activity of Xenopus NFAT, a homolog of human NFATc3, in ventral part of 
embryo and induces dorsal-ventral axis formation (Saneyoshi et al., 2002). Furthermore, 
XNFATc3 was found to affect neural convergent extension during Xenopus embryo 
development (Borchers et al., 2006). 
  NFAT signaling is crucial for the development and function of cardiovascular 
system. In adult heart, calcineurin-NFAT signaling is believed to be involved in cardiac 
hypertrophy. Expression of constitutively active calcineurin in the hearts of transgenic 
mice results in heart hypertrophy, and  calcineurin inhibitor FK506 and CsA can prevent 
myocyte hypertrophy in vitro and block cardiac hypertrophy in vivo (Shimoyama et al., 
1999). Cardiac hypertrophy is characterized by activation of fetal program of cardiac gene 
expression.  It has been found that NFATc4 interacts with GATA4 to regulate those 
cardiac genes expression such as b type natriuretic peptide (BNP) (Molkentin et al., 1998). 
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In agreement with this finding, expression of constitutively activated NFATc4, an N-
terminal regulation domain truncated NFATc4, in mice hearts results in cardiac 
hypertrophy (Molkentin et al., 1998).  
  NFAT signaling is involved in embryonic cardiogenesis in many ways. Firstly, 
NFAT signal is important for heart valve development. Heart valve formation is initiated 
when endocardial cells from the cardiac cushion undergo endocardial-mesenchymal 
transformation (EMT). The mesenchymal cells then proliferate, differentiate and reshape 
the rudimentary valve into slender leaflet.  It has been found that NFATc2, c3 and c4 
activities in myocardium are required for EMT during the onset of heart valve formation 
at E9.0 (Chang et al., 2004). NFAT transcriptionally inhibits the expression of VEGF, a 
negative regulator of EMT, thereby initiating heart valve and septum formation (Chang et 
al., 2004). NFATc1 is required for later stage of heart valve formation. During mouse 
embryo day E11-12, NFATc1 is specifically expressed and translocated to the nucleus of 
endocardial cells in cardiac cushion, to direct valvular elongation and refinement. Both 
genetic targeted depletion of  NFATc1 and applying FK506 and CsA in mice result in 
defect in outflow tract valves and the septum separating the two atria, and the mice died 
by E13.5 due to the malfunction of heart (de la Pompa et al., 1998; Ranger et al., 1998).   
  Secondly, NFAT activity is crucial for myocardium development. Combinatorial 
disruption of NFATc3 and NFATc4 in mice causes myocardium and vascular deficiency 
which result in embryonic lethality at E10.5(Bushdid et al., 2003; Graef et al., 2001). The 
role of NFATc3/c4 in developing vasculature was revealed by Graef’s group. They found 
impaired blood vessel assembly and excessive and disorganized growth of vessels into the 
neural tube and somites in NFATc3/c4 deficient mice (Graef et al., 2001). The vascular 
defects in the CnB mutant mice resemble those of the NFATc3/c4 null mice, suggesting 
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that the calcineurin-NFAT signaling is crucial for direct vascular formation in mice. By 
using CsA to inhibit calcineurin-NFAT signaling during different periods of embryos 
development, Graef et al identified a narrow window (E7.5-8.5) in which NFAT activity is 
required for angiogenesis. Although Graef fail to find significant heart defects in 
NFATc3/c4 null mice, another group reported that NFATc3/c4 deficiency did affect 
myocardial development. In that report, Bushdid et al found that NFATc3/c4 null mice 
have thin ventricles, pericardial effusion, and a reduction in ventricular myocyte 
proliferation (Bushdid et al., 2003). Interestingly, mitochondria in the cardiac cells of 
NFATc3/c4 null mice also exhibit an abnormal swollen morphology with crista 
malformation. MRC complex II and IV activity were also impaired in the cardiac cells, 
which suggest that NFAT activity is involved in regulation of mitochondrial energy 
metabolism during heart development. Both heart defect and mitochondrial malformation 
can be rescued by cardiac-specific expression of constitutively active NFATc4, which 
confirmed the specific role of NFATc4 in mitochondrial energy metabolism and heart 
development. The role of NFATc3/c4 in heart development does not contradict with the 
role of NFATc3/c4 in vascular development. It has been known that functional heart and 
sufficient hemeodynamics is crucial for the vascular development (Luo et al., 2001). For 
example, mice with deficiency of Nkx2.5 (Nk2 transcription factor related, locus 5), a 
gene specifically expressed in cardiac but not vascular lineage, showed both arrest of 
cardiac development and poor development of blood vessels. These data suggests that the 
impaired angiogenesis could be the secondary effect of loss functional heart (Tanaka et al., 
1999a). The role of NFAT in regulating myocardium development was further confirmed 
by the study using dominant negative NFAT transgenic mice (Schubert et al., 2003). In 
that study, NFAT proteins were found to be translocated into nucleus of myocardium cells 
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between embryonic day 14 and P0 (birth). A α-myosin heavy chain (MHC) promoter was 
used to drive dominant negative NFAT in the atrial myocardium of transgenic mice.  
Inhibition of NFAT activity by dominant negative NFAT causes thinning of atrial 
myocardium in transgenic mice. The thin myocardium exhibits severe sarcomere 
disorganization and reduction in the expression of cardiac structure genes such as cardiac 
troponin-l (cTnl) and cardiac troponin-T (cTnT). Furthermore, NFAT was found to 
directly regulate cTnl and cTnT transcription through binding on their promoter. In 
summary, NFATs play multiple roles in cardiovascular development. The Ca2+/ calineurin 
dependent NFAT activity is crucial for myocardium development and angiogenesis at 
early stage of cardiogenesis during mouse embryonic day E7.5-8.5. It is also response to 
cardiac valve and septum development between E9-12 and atrial myocardium 
development from E14 to P0.  As transcriptional factor, NFATs regulate the expression of 
VEGF and cardiac troponins genes which are responsible for the development of heart 
valve and cardiac structural architecture respectively in later stages. However, the 
molecular mechanism of NFAT in early cardiogenesis is largely unknown. 
 
1.3. Cardiogenesis 
  The heart is the first organ to function in vertebrate embryos and cardiac lineage is 
among the first to be specified during embryo development. In mice, the heart 
development is initiated during late gastrulation (around mouse embryonic day E 7.5)  
when the anterior lateral mesoderm is specified to a cardiac fate under induction of signals 
from adjacent tissues (Sater and Jacobson, 1989; Schneider and Mercola, 2001; 
Schultheiss et al., 1995). The cardiac precursor cell from this region, known as cardiac 
crescent, converge to the ventral midline and form the linear heart tube by E8.0. The heart 
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tube is composed of an inner endothelial tube shrouded by a myocardial layer. This 
primitive heart tube then undergoes elongation and right looping. During the looping, the 
atrial portion shifts dorsally and cranially, and the future ventricles become distinct and 
balloon outward. The endocardial cells in the boundary between atrial and ventricle 
portions proliferate and migrate to form opposing tissue masses termed endocardial 
cushion by E9.5. The endocardial cushion further elongates and undergoes continuous 
remodeling to form thin valve leaflets between atria and ventricles.  Endocardial cushion 
also forms in outflow region of mammal heart, giving rise to the aortic and pulmonary 
valves. All of the cardiac valves are formed by E 13. Beside the endocardial cushion 
which separates atria and ventricles, septums also form in the common atrium and 
ventricles around E10.5 to separate both of them into left and right portions. All the 
separations finish by E14, and embryonic heart acquires a definitive four-chamber 
structure (Fishman and Chien, 1997; Olson and Srivastava, 1996).   
 
1.3.1. Molecular pattern in cardiaogenesis 
  Although the heart formation has been well described morphologically, the 
molecular mechanism underlying this process remains to be revealed. It has been known 
that the heart progenitor cells in anterior mesoderm adopts a cardiac fate in response to the 
signals from adjacent endoderm (Olson, 2001). The induction signals in the cardiac 
initiation stage include bone morphogenetic protein (BMP) family members, fibroblast 
growth factors (FGF), and Wnt proteins (Eisenberg and Eisenberg, 1999; Pandur et al., 
2002; Reifers et al., 2000; Schneider and Mercola, 2001; Schultheiss et al., 1997). BMPs 
belong to a subset of the transformation growth factor-β (TGFβ) superfamily. BMP 
members are expressed in endoderm adjacent to the heart formation region in avian. 
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Blocking BMP signaling by BMP antagonist noggin in chick precardiac mesoderm results 
in inhibition of cardiogenesis. Application of BMP2, or BMP4, to chick anterior 
mesoderm induces ectopic cardiogenesis (Andree et al., 1998; Schultheiss et al., 1997). 
Similarly, in drosophila, a BMP- related factor, DPP, is secreted from ectoderm and 
induce the underlying dorsal mesoderm to become cardiogenic (Frasch, 1995; Xu et al., 
1998). Furthermore, the effectors of BMP signaling, Smad transcription factors, has been 
shown to directly activate genes encoding cardiac transcriptional factors such as Nkx2.5 
during heart development (Liberatore et al., 2002; Lien et al., 2002). In low concentration, 
BMP also induce FGF8 expression in the endoderm adjacent to precardiac mesoderm, 
where FGF8 signaling cooperates with BMP signaling to regulate early cardiogenesis 
(Alsan and Schultheiss, 2002). In addition to playing a role in the initiation of cardiac 
precursor cells, BMP4 is also expressed in heart tube and involved in heart tube looping 
(Breckenridge et al., 2001).  
  In contrast to the positive role of BMP in heart development, Wnt proteins have 
both positive and negative roles in establishing cardiac lineage. The Wnt proteins are 
secreted growth factors which bind on various frizzled receptor and trigger several 
different pathways. The best known canonical Wnt pathway signals through dishevelled 
and results in the stabilization of cytoplasmic β-catenin.  β-catenin then tanslocate to the 
nucleus and forms a transcriptional complex with TCF/LEF family of HMG-box 
transcription factor to activate downstream genes expression. Wnt proteins that activate 
this pathway comprise of the Wnt1 class including Wnt1, Wnt3 and Wnt8. 
Overexpression of Wnt3a and Wnt8 blocks cardiogenesis in Xenopus (Tzahor and Lassar, 
2001), and Wnt antagonists (crescent and Dickkopf-1) have been shown to be expressed in 
anterior endoderm to disinhibit cardiac specification in the adjacent mesoderm (Hurlstone 
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et al., 2003; Monaghan et al., 1999; Schneider and Mercola, 2001). In contrast to the 
inhibition effect of canonical Wnt pathway on cardiogenesis, activated non-canonical Wnt 
pathway seems to induce cardiogenic differentiation.  Upon binding to certain members of 
the Wnt receptors, non-canonical Wnts (Wnt4, Wnt5A or Wnt11) are able to activate Jun 
N-terminal kinase (JNK) and elicit an intracellular release of calcium ions (Kuhl et al., 
2000). This calcium signaling is sufficient to activate calcium sensitive enzymes, such as 
protein kinase C, calcium-calmodulin dependent kinase II, or calcineurin. This non-
canonical Wnt pathway has been described in Xenopus to activates NFAT and promotes 
ventral cell fate(Pandur et al., 2002; Schroeder et al., 1999). A non-canonical Wnt protein, 
Wnt11, was found to be enriched in precardiac mesoderm in both mouse and avian 
embryo. Disruption of Wnt11 results in defect of cardiaogenesis and Nkx2.5 gene 
expression in Xenopus, and the JNK pathway has been shown to be mediated in Wnt11 
induced cardiogenesis. Together, the initiation of cardiac fate in anterior lateral mesoderm 
requires the various induction signals from adjacent tissues including BMP, FGF, non-
canonical Wnt11 protein and antagonists for canonical Wnt pathway.  
  Upon induction, the cardiac precursor cells express several core transcription 
factors, such as Nkx2.5, GATAs, MEF2, Hand1/2 (heart and neural crest derivatives 
expressed transcript 1 or 2) and Tbx (T-box transcription factor). These core transcription 
factors cooperate with each other to establish a positive cross-regulation network and start 
carcinogenic programme by regulating their downstream cardiac gene expression (Harvey, 
2002; Olson, 2006). This transcriptional networked is illustrated in Figure1.6. 
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Figure 1.6.  Schematic of transcriptional network involved in cardiogenesis. 
   
   Nkx2.5 is probably the earliest genes to be expressed in cardiac progenitor cells in 
response to induction signals. It controls heart development through activating multiple 
cardiac specific genes including the core transcriptional factors. The role of Nkx2.5 in 
cardiaogenesis will be discussed in detail in the following section.  
  MEF2 is a myogenic transcriptional factor known to regulate the differentiation of 
all muscle types. It cooperates with MyoD family proteins to induce the differentiation of 
skeletal muscle. Whereas, in cardiac muscle, it cooperate with cardiac key transcription 
factors such as Nkx2.5 and GATA to regulate the expression of myofibrillar proteins 
(McKinsey et al., 2002; Morin et al., 2000)  
Inductive signals 
(BMP,FGF,Wnt, et. al) 
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  Members of GATA family of zinc finger transcription factor (GATA4, 5 and 6) 
are expressed in the cadiogenic mesoderm and directly regulate a number of cardiac 
contractile protein genes through interaction with other core transcriptional factor such as 
Nkx2.5 and MEF2C (Olson, 2006). GATA4 also regulates the expression of the upstream 
core transcription factors such as Nkx2.5, MEF2 and Hand. Mice lacking GATA4 form 
cardiac progenitor cells in anterior lateral mesoderm, but these regions fail to migrate to 
midline and form heart tube (Kuo et al., 1997; Molkentin et al., 1997). Further more, it has 
been found that GATA6 transcription in heart is dependent on the Nkx2.5. Thus the 
Nkx2.5 and GATAs mutually reinforce their transcription and synergistically regulate the 
cardiac gene expression.     
  Tbx genes are family of transcription factors that are differentially expressed 
within the limb buds of the embryos. Tbx2, 3, 5 and 20 also display overlapping 
expression in cardiac lineage (Plageman, Jr. and Yutzey, 2005; Yamada et al., 2000). 
Tbx5 has been shown to associate with Nkx2.5 and synergistically promote 
cardiomyocyte differentiation (Hiroi et al., 2001). Mutations in Tbx5 in human are 
associated with Holt-Oram syndrome which leads to abnormalities of upper limb and heart 
(Li et al., 1997). Gene disruption of Tbx5 in mice results in defect of the posterior region 
of heart tube.   
  The Hand gene family encodes highly conserved basic helix-loop-helix (bHLH) 
transcription factors that play crucial roles in cardiac development especially in ventricular 
growth. Amphibian and fish, which have one ventricle in heart, express single hand gene. 
Mutation of hand in zebrafish results in defect of ventricular chamber (Yelon et al., 2000). 
Higher vertebrates which have four-chamber heart express two hand genes, Hand1 and 2. 
Hand1 and Hand2 are initially expressed throughout the cardiogenic region but later 
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display complementary expression patterns in the left and right ventricular chambers 
respectively. Mice lacking Hand2 die from right ventricular hypoplasia (Srivastava et al., 
1997; Yamagishi et al., 2001), whereas hand1 mutant embryonic stem cells fail to 
contribute to the outer curvature of left ventricular myocardium (Riley et al., 2000).  
 
1.3.2. The role of Nkx2.5 in cardiogenesis 
  In Drosophila, a homeobox containing transcription factor, tinman, is specifically 
expressed in the dorsal mesodermal cells fated to form dorsal vessel, an insect equivalent 
of vertebrate heart (Bodmer et al., 1990). Disruption of tinman gene results in the total 
deficiency of dorsal vessel, indicating that tinman is required for early steps in 
cardiogenesis (Azpiazu and Frasch, 1993; Bodmer, 1993)   
  Five vertebral tinman-related Nk2-homeobox genes, Nkx2.3, Nkx2.5, Nkx2.6, 
Nkx2.7 and Nkx2.8, are expressed in cardiac and pharyngeal lineages in an overlapping 
pattern (Komuro and Izumo, 1993; Lints et al., 1993; Biben et al., 1998; Evans et al., 
1995; Lee et al., 1997; Reecy et al., 1997).  Among them, Nkx2.5 is the earliest one to be 
expressed in the cardiac progenitor cells. It is expressed in precardiac mesoderm in mouse 
embryos right after gastrulation (E7.5). By E8.5, Nkx2.5 is homogeneously expressed in 
the myocardium and continues to be strongly expressed in heart throughout the embryonic 
stage to adulthood (Komuro and Izumo, 1993; Lints et al., 1993). Like other Nkx 
members, Nkx2,5 is also expressed in the pharyngeal endoderm which gives rise to 
pharyngeal arches, spleen, thyroid, stomach and tongue during embryo 
development(Komuro and Izumo, 1993; Lints et al., 1993). Over-expression of Nkx2.5 in 
Xenopus and zebrafish  increases heart size and promotes cardiac gene expression (Chen 
and Fishman, 1996; Cleaver et al., 1996). In mice lacking Nkx2.5, cardiac linage still 
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initiates but  the embryos is dead by E9.5-11.5 due to failure in heart tube looping(Cleaver 
et al., 1996; Lyons et al., 1995; Tanaka et al., 1999a). Nkx2.5 mutation in human results in 
congenital cardiac malformation and atrioventricular conduction abnormality (Schott et 
al., 1998). The relative late effect of Nkx2.5 depletion on cardiac morphogenesis contrasts 
with the early function of tinman in specification of cardiac cell fate, which is probably 
due to the functional redundancy of other Nkx2 proteins. Indeed, combined expression of 
dominant negative Nkx2.5 and Nkx2.3 in Xenopus embryos results in more severe 
phenotype than mutation of  either protein alone (Grow and Krieg, 1998; Fu et al., 1998). 
The mutation of Nkx2.5/Nkx2.3 leads to lost of cardiac markers expression in precardiac 
mesoderm, and absent of morphologically distinguishable heart in later stage, suggesting 
Nk2- homeobox family plays an essential role of in early cardiogenesis.  
  Disruption of Nkx2.5 in mice disturbs multiple cardiac genes expression such as 
ANF, BNP, MLC2V, N-myc, MEF2C, Hand1, Msx2 and cardic actin.  However, the 
expression of GATA4, BMP-4, Msx1 and Hand2 were not affected in the Nkx2.5 null 
heart, which suggested those genes may not be downstream targets of Nkx2.5.  Nkx2.5 
regulates gene expression through binding on NKE sequence elements 5’-NAAGTG-3’. 
These NKE elements are required for the expression of various cardiac genes including 
cardiac actin, D-MEF2 and atrial natriuretic factor (Chen and Schwartz, 1996; Gajewski et 
al., 1998). Nkx2.5 synergistically interacts with other cardiac transcription factor such as 
GATA4, serum response factor (SRF) to bind on NKE elements and regulate downstream 
genes expression (Chen et al., 1996; Sepulveda et al., 1998). Besides regulating the 
expression of other cardiac genes, Nkx2.5 itself is regulated by cardiac induction signals 
and cardiac transcriptional factors (Lien et al., 1999; Lien et al., 2002). 
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1.3.3. Transcriptional regulation of Nkx2.5 
  Studying the regulation of Nkx2.5 is of particular interest since activation of 
Nkx2.5 in precardiac mesoderm present the initial step of cardiogeneis. Elucidating the 
regulation mechanisms of Nkx2.5 will help to understand how the cardiac lineage is 
specified and maintained. Mouse Nkx2.5 gene is encoded by two major exons (Exon 1 
and 2) and two small alternative exons (Exon 1a and 1b) on the 3-4 kb upstream of exon 1 
(Reecy et al., 1999; Tanaka et al., 1999b). The 14 kb of 5’ flanking sequence of Exon 1 is 
crucial in driving Nkx2.5 expression in cardiac lineage (Lien et al., 1999; Reecy et al., 
1999; Searcy et al., 1998; Tanaka et al., 1999b). In the mouse bearing the 14 kb sequence-
lacZ reporter transgene, lacZ expression was observed in cardiac crescent at E7.5, and 
later in the outflow tract, atrial septum and ventricular chamber. LacZ was also expressed 
in pharynx thyroid and stomach in this transgenic mouse, suggesting this sequence is also 
responsible for the expression of Nkx2.5 in other lineages. Through serial deletion of this 
14 kb of 5’ flanking sequence linked to the lacZ reporter, two cardiac enhancers, 
activation region (AR) 1 and 2, has been identified (see Figure 4.4. in Chapter 4). AR1 (-
9637 to -7555) is localized 7-9 kb upstream of Nkx2.5 gene and contains three regulatory 
regions. The 513 bp sequence in 5- terminal AR1 is a minimal cardiac enhancer which is 
able to drive the lacZ reporter to be expressed in cardiac tissue from the onset of cardiac 
lineage specification to the looping heart tube. At E11, the activity of this minimal 
enhance is restricted to the right ventricle. The middle part of AR1 is an 883 bp inhibitory 
element which is localized immediate downstream of the minimal enhancer and strongly 
inhibits the activity of the enhancer. This inhibitory effect can be overcome by the third 
part of AR1, a 686 bp sequence downstream of the inhibitory element, although this 
positive regulatory element lacks transcriptional activity by it own.  
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  Another cardiac enhancer, AR2 (-3299 to -2795) is localized around 3 kb upstream 
of Nkx2.5 gene. In the transgenic mouse, this 505 bp enhancer drives lacZ expression in 
the primitive heart tube at E8.5 and in the developing outflow tract of the heart, 
pharyngeal clefts and spleen later in development. The sequence of AR2 and the minimal 
enhancer in AR1 are highly conserved among mice, chick and human, suggesting that the 
mechanisms of Nkx2.5 regulation are also conserved among different species (Lien et al., 
2002). Indeed,  it has been known that several transcription factors bind onto the 
conserved sites of these two   enhancers and regulate Nkx2.5 gene expression including 
Smad and GATA family proteins (Lien et al., 1999; Lien et al., 2002; Searcy et al., 1998; 
Shaw et al., 1988). AR1 contains a conserved GATA binding site (-9570). Mutation of 
this site abolished the cardiac activity of AR1 enhancer (Lien et al., 1999). Similarly, 
mutation of the two conserved GATA sites (-3034 and -3022) in AR2 compromised the 
transcriptional activity of AR2 in heart as well as pharynx and spleen (Searcy et al., 1998). 
In addition to GATA, BMP signaling also regulates Nkx2.5 gene expression. It has been 
found that Smad, the transcriptional effector of BMP signaling, binds on a conserved 
Smad sits on AR2 and regulate the cardiac activity of this enhancer. Although crucial for 
regulation of Nkx2.5 expression in heart, both GATA and BMP are expressed more 
broadly than in heart. Furthermore, there is no evidence that GATAs and BMPs 
expression precede the expression of Nkx2.5 in heart. Thus there must be other factors 
that cooperate with BMP and GATA to regulate Nkx2.5 expression in heart. As mentioned 
before, the initiation of cardiac lineage needs to integrate multiple signals such as BMP, 
FGF and Wnt proteins. These signals could be important in inducing the Nkx2.5, the 
earliest cardiac marker, to be expressed in heart.   
 
                                                                                                                               Chapter 1  
                                                                                                                                             41 
1.4. Rationale of this thesis  
  
  Mitochondria disease is one of the most common genetic diseases. 60% of 
mitochondria diseases are caused by MRC defect especially by the mutation in nDNA 
encoded MRC subunits. The MRC defect mainly results in malfunctions of neuronal, 
muscular and cardiac systems in patients. The severity of clinical phenotypes is dependent 
on functional remains of MRC in the patient. MtDNA mutation affects only partial of the 
mitochondria in cells, which causes a less severe phenotype and has a late onset. On the 
contrary, nDNA mutation usually results in distinct clinical phenotype such as fatal 
infantile cardioencephalomyopathy in infancy or early childhood. These early onset 
disorders may be initiated from early stages of embryo development. Indeed, depletion of 
TFAM in mice compromised heart development and resulted in lethality around 
embryonic day 10.5. Depletion of GRIM-19 in mice resulted in embryonic lethality even 
earlier in E9.5. These data suggest the crucial role of MRC in embryo development. 
Studying the roles of MRC in embryo development will help us to understand the 
pathogenesis and molecular mechanism of MRC diseases. Due to the early embryonic 
lethality in MRC deficient mice, an animal model with a partially inhibited MRC is 
needed for this purpose.  In this study, we knocked down GRIM-19 in Xenopus laevis 
embryos and aimed to study the role and the underlying mechanism of MRC in controlling 
Xenopus embryo development. This study led us to define a crucial role of MRC in early 
cardiogenesis and identify a specific pathway, calcium-calcineurin-NFAT pathway, as 
MRC downstream signal in regulation of cardiac development. This part of data was 
described in Chapter 3. During this study, we also found that ectopic expression of 
constitutively active NFAT in Xenopus embryo remedied the defect of cardiac 
morphology and cardiac marker, Nkx2.5 gene expression in GRIM-19 knocking down 
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embryos. This suggests that NFAT may act as an upstream effector of regulate the Nkx2.5 
gene expression during cardiogenesis. In Chapter 4, I will present the second part of the 
study: NFAT directly regulates Nkx2.5 transcription during cardiogenesis.      
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2.1. Materials 
Histamine was obtained from Fluka. Fura2-AM, F-127, ionomycin, and antibody 
against NDUFS3 were purchased from Molecular Probes. All-trans-retinoic acid (RA), 
FK506 and Cyclosporin A (CsA), phorbol 12-myristate-13-acetate (PMA), rotenone and 
antibodies against actin and Hsp60 were from Sigma. Anti-NFATc4 and VDAC 
antibodies were purchased from Calbiochem. Anti-CD3 and CD28 antibodies were from 
eBioscience. Anti- GP130 antibody was from Santa Cruz. Antibody against mouse GRIM-
19 was generated as described (40). This ant-GRIM-19 antibody also cross-reacts with 
human and Xenopus GRIM-19 protein.  
 
2.2. Construction of plasmids 
Human GRIM-19 cDNA was amplified by RT-PCR from HeLa cells, and cloned 
into BamH1 and Xba I sites of PCS2 vector. Mouse NFATc4 full-length cDNA was 
purchased from ATCC. The constitutively activated NFATc4 (CA-NFATc4) was made by 
deleting the first 317 amino acids from the wide-type NFATc4 according to a previous 
report (Molkentin et al., 1998). NFATc4 and CA-NFATc4 were subcloned into EcoR1 and 
Xho1 sites of either pCDNA3 or PCS2 vectors. Full-length cDNA of Nkx2.5, MLC, 
BMP4, GATA4, and cardiac actin were amplified from stage 28 Xenopus embryo mRNA 
by RT-PCR using one-step RT-PCR kit (Qiagen), and cloned into pDrive vector using 
PCR cloning kit (Qiagen).  pBlue-script 3059 bp Nkx promoter-LAZ  vector was kindly 
provided by Dr.Yutzey (The Children’s Hospital Research Foundation, Cincinnati, OH.). 
Lac-Z was cut by Xba1 and replaced by luciferase gene from PGL3 –promoter vector to 
generate Nkx2.5 3 kb promoter luciferase reporter constructs. CR1 of Nkx2.5 promoter (-
9376 to- 9679) was amplified by PCR from mouse genome and cloned into Kpn1/Xho1 
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site of PGL3 promoter vector to make PGL3-CR1 enhancer construct. NFAT site mutation 
constructs were generated by QuikChange® Site-Directed Mutagenesis Kit (Stratagene). 
Transfection of plasmids to cells was performed using Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s instructions. 
 
2.3. Cell culture  
HeLa (human cervical adenocarcinoma) cells were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS) (Gibco) 
and supplemented with 2 mM L-glutamine(Gibco), 100 Units/ml penicillin and 100 ng/ml 
streptomycin. MCF-7 (human breast carcinoma) cells were cultured in RPMI 1640 
supplemented with 10% FBS, 100 Units/ml penicillin and 100 ng/ml streptomycin, and 
0.1 mM MEM non-essential amino acids (Gibco). P19 ( mouse embryonic carcinoma) 
cells were obtained from the American Type Culture Collection (ATCC) and were 
cultured in α-minimum essential medium (Invitrogen) supplemented with 7.5% (v/v) 
Cosmic Calf Serum ( Gibco), 2.5% (v/v) FBS, 100 Units/ml penicillin and 100 ng/ml 
streptomycin. Jurkat (human T-cell leukemia) cells (ATCC) were cultured in RPMI 1640 
medium containing 10% FBS, 1 mM sodium pyruvate (Gibco), 2 mM L-glutamine, 100 
Units/ml penicillin and 100 ng/ml streptomycin.  
 
2.4.  Preparation of DH5α Escherichia coli competent cells 
DH5α Escherichia coli competent cells were prepared by growing an aliquot of 
the competent cells in 100 ml Luria Bertani (LB, pH 7.5) containing 1% bacto-tryptone, 
0.5% bacto-yeast extract, and 1% NaCl, at 37oC shaker until the absorbance at 600 nm 
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reached 0.45 - 0.55. The culture was chilled on ice for 15 min, and sedimented with 
centrifugation at 3,000 rpm at 4oC for 10 min. The pellet was resuspended in 1/3 volume 
with RF1 buffer, pH 5.8, (100 mM KCl, 50 mM MnCl2.4H2O, 30 mM KOAc, 10 mM 
CaCl2.6H2O, 15% w/v glycerol, and adjusted to pH 5.8 with 0.2 M acetic acid), and the 
cell suspension was placed on ice for 15 min to 2 h, followed by centrifugation at 3,000 
rpm at 4oC for 10 min. The pellet was resuspended in 1/12.5 volume with RF2 buffer, pH 
6.8, (10 mM MOPS, 10 mM KCl, 75 mM CaCl2.6H2O, 15% w/v glycerol, and adjusted to 
pH 5.8 with NaOH), and placed on ice for 15 min. The competent cells were aliquoted and 
stored in -80oC. 
 
2.5. DNA transformation  
Transformation of plasmids into competent cells was performed using the heat 
shock method. The plasmid was incubated with 100 µl of the DH5α Escherichia coli on 
ice for 30 min. The competent cells were heat shocked at 42oC for 60 sec, and 
immediately placed on ice for 2 min. Recovery was performed by adding 900 µl of LB to 
the competent cells, and cultured at a 37oC shaker for 1 h. The bacterial culture was 
spread onto a LB agar plate containing 50 µg/ml ampicillin, and incubated at 37oC 
overnight. Single colonies were subjected to screening by mini scale preparation of DNA 
and subsequent diagnostic restriction digestion and/or sequencing. 
 
2.6. Lipofectamine 2000 DNA transfection 
Cells were seeded in 6 well culture dish approximately 24 h prior to transfection. A 
total of 3 µg DNA plasmids (0.6 µg renilla + 1.4 µg reporter plasmids + 1 µg NFAT 
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constructs in reporter assay) in a final volume of 100 µl OPTI-MEM® I (reduced serum 
media from Gibco) was added to a second solution containing 3 µl Lipofectamine 2000 
(Gibco) and 100 µl OPTI-MEM I. The mixture was incubated at room temperature for 15 
min to allow the DNA-liposome complexes to form. An additional 1.5 ml of OPTI-MEM I 
was gently mixed to the complexes and the mixture was subsequently overlayed onto the 
cell culture, and incubated for 4 h at 37oC. Cells were washed with PBS twice, replaced 
with complete growth medium, and incubated at 37oC for future experiment. 
 
2.7.  Xenopus embryo manipulation  
The Xenopus protocol was approved by the Biological Resource Center 
Institutional Animal Care and Use Committee, Biopolis, Singapore. Embryos were 
fertilized in vitro, dejellied in 2% cysteine-HCl (pH 7.8), and maintained in 0.1X MMR 
(0.1 M NaCl, 2.0 mM KCl, 1 mM MgSO4, 2 mM CaCl2, 5 mM Hepes, pH7.8, and 0.1 
mM EDTA) supplemented with 50 µg/ml gentamycin. To inhibit complex 1 activity, 0.5 
µM rotenone or DMSO (solvent for rotenone) was added to the 0.1X MMR at stage 12. 
Embryos were staged according to Nieuwkoop and Faber (29). The antisense XGRIM-19 
morpholino oligonucleotides (MO) was purchased from Gene Tools. Sequence for MOs 
are:  
XGRIM-19 MO1: 5’-AGCTTAGTTTCTGTCGAAGACCTCT-3’;  
XGRIM-19 MO2: 5’-CCTGTTTCACCTTGGACGCCGCCAT-3’;  
Control MO: 5’-AGGTTACTTTGTG TGGAAGACGTCT-3’.  
Capped mRNA for injection was transcribed from plasmids pCS2-hGRIM-19 and 
pCS2-CA-NFATc4 by SP6 polymerase (Roche), which is described in 2.8. For 
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morpholino knockdown experiments, 20 ng of MOs was injected into stage 1 embryos. 
For the rescue experiments, 500 pg of human GRIM-19 or CA-NFATc4 mRNA was 
injected in two dorsal cells of stage 3 embryos after MO injection at stage 1. A fluorescent 
dye FDA was co-injected with mRNA to monitor the correct delivery of mRNA into 
dorsal region. 
 
2.8.  Isolation of cDNA clones of Xenopus laevis GRIM-19   
 
2.8.1. Prepare Xenopus tropicalis GRIM-19 cDNA probe 
Xenopus tropicalis GRIM-19 cDNA was released from pCMV-SPORT6-GRIM-19 
plasmid (ATCC) by EcoR1/Xho1. The cDNA was radioactively labeled by α32–pCTP 
using the high prime DNA labeling kit (Roche).  
 
2.8.2.  Screening of Xenopus laevis oocyte cDNA library 
1.5 X 105 bacteria from Xenopus laevis oocyte cDNA library (ATCC) was plated 
on 20 Hybond-N nylon membranes. The membranes were then put on the LB plate and 
culture overnight at 37oC. The membranes were dried at room temperature for 30 minutes 
on Whatmann papers and placed sequentially on the top of  Whatmann papers saturated 
with 0.5M NaOH / 1.5 NaCl  for 2 minutes, 0.5 M Tris/HCl (pH 8.0) / 1.5M NaCl for 5 
minutes and 2 X SSC for 30 seconds. The membranes were then dried on Whatmann 
papers and the DNA was crosslinked to membranes using a UV crosslinker (Stratagene). 
The membranes were prewashed in 0.1 X SSC, 0.1% SDS at room temperature  for 10 
minutes and prehybridized in prehybridization buffer (6 X SSC, 5 X Denhardt’s buffer, 
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100 µg/ml salmon sperm DNA 0.1% SDS and 50% formamide) at 42oC for 4 hours. 
Subsequently, 1 X 106 cpm/ml denatured probe was added into the prehybridization buffer 
and  hybridized at 42oC overnight. The membranes were then washed two times with low 
stringent buffer ( 2X SSC, 0.1% SDS) at 42oC for 30 minutes and high stringent buffer  ( 
0.2X SSC, 0.1% SDS) at 42 and  55 oC each for 30 minutes. The washed membranes were 
exposed to X-ray film overnight at -80oC. The bacterial clones from positive spots of first 
screening were picked up and plated on LB plates to conduct the second screening in order 
to identify the individual clones. Two Xenopus laevis GRIM-19 (XGRIM-19) cDNA were 
identified with different length after the second screening. The ORF of XGRIM-19 cDNA 
was then cloned into HindIII and EcoRI sites of both pcDNA3 and pDrive vector (Qiagen) 
for in vitro transcription/translation assays and probes for in situ hybridization, 
respectively.  
 
2.9. QuikChange™ Site-Directed Mutagenesis 
Site-directed mutagenesis was introduced into the NFAT sites of plasmids by 
QuikChange™ Site-Directed Mutagenesis Kit (Stratagene). The mutagenic 
oligonucleotide primers were designed accordingly with the desired mutation placed in the 
middle of the primer and ~ 10 - 15 bases of correct sequences on both sides. Sense primers 
used are outlined below, with the substitution mutation underlined:  
-1176 mut: 5’- GATTACAGCAGTCAAAAGTCCCACTC -3’;  
-1910 mut: 5’- GTGGCAAGGGAGTCAAACAAAACAAAAC -3’; 
-2910 mut: 5’- GCTGATTGCAGTCAAGGGGGGGCGC -3’; 
-3073 mut: 5’- ACCCCCATCTGTTGACCTGGCGCGG-3’;  
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-9460 mut: 5’- TCTTCCCCGGAGTCAAACTTCTTGCC -3’ 
-9513 mut: 5’- TGGCCCGACAGTCAACTCGGAGCTA -3’.  
Sample reactions were prepared in thin-wall PCR tubes. 1 µl of Pfu Turbo™ DNA 
Polymerase (2.5 U/µl) was added to 50 µl of deionised water containing 5 µl of 10X 
Reaction Buffer, 30 ng dsDNA template, 125 ng oligonucleotide primer #1 (sense), 125 
ng oligonucleotide primer #2 (antisense), and 1 µl of dNTP mix. The reactions were 
heated up to 95oC for 30 sec, followed by 16 cycles of denaturation at 95oC for 30 sec, 
annealing at 50oC for 1 min, and extension by the nonstrand-displacing action of Pfu 
Turbo DNA Polymerase at 68oC for 16 min 30 sec (2 min/kb of plasmid length). The 
reactions were cooled to 16oC at the end of the cycle, and the methylated, nonmutated 
parental DNA template was digested with DpnI at 37oC for 1 h. The circular, nicked, 
mutated dsDNA was transformed into Epicurian Coli® XL1-Blue supercompetent cells 
(Stratagene, La Jolla, CA, USA) using the heat shock method, and the nicks in the mutated 
plasmid were subsequently repaired by the supercompetent cells.  
 
2.10. Prepare RNA probe or caped mRNA by in vitro transcription 
To make digoxygenin-labeled probes, pDrive vector containing full length of 
Nkx2.5, MLC, BMP4, GATA4, and cardiac actin gene were linealized at N terminal of 
each gene. In vitro transcription reaction was performed using DIG RNA labeling kit 
(Roche) following the manufacturer’s instructions. Briefly,  1µg linealized plasmids were 
incubated with 1 x NTP labeling mixture, 1 x  transcription buffer,  1 µl RNase inhibitor 
and 2 µl of RNA polymerase SP6/T7 for  2 hours at 37 °C.  After determine the yield and 
quality of probes by agarose gel electrophoresis, the probe was passed through microcon 
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columns (amicon) to remove unincorporated nucleotides and stored in hybridization buffer 
at -20 °C before used for hybridization. 
To prepare capped mRNA for embryo injection, plasmids pCS2-hGRIM-19 and 
pCS2-CA-NFATc4 was linealized by restrict enzyme Not1. 1µg linealized plasmids were 
incubated with 1 x NTP mixture ( 0.6 mM ATP, 0.6 mM CTP, 0.6 mM UTP, 0.3 mM 
GTP and 0.9 mM  7-methyl-GpppG) ,  1 x  transcription buffer,  1 µl RNase inhibitor and 
2 µl of RNA polymerase SP6 for  2 hours at 37 °C. After determine the yield and quality 
of the capped mRNA by agarose gel electrophoresis, the RNA were precipitated by 
TRIZOL reagent (Invitrogen), resuspended in RNase free H2O and stored in -80°C. 
 
2.11.  Whole-mount in situ hybridization 
Embryos at indicated stages were fixed for 1 hour at room temperature in MEMFA 
buffer (100 mM MOPS, pH 7.4, 2 mM EGTA, 1 mM MgS04  and 3.7% formaldehyde), 
followed by post-fixation in methanol and storage at - 20°C. After rehydration in gradual 
methanol from 100% to 25%, embryos were equilibrated to PTw buffer (1.85 mM 
NaH2P04, 8.5 mM Na2HP04, pH 7.4, 175 mM NaCl, 0.1% Tween-20), and treated with 10 
µg/ml proteinase K for 5 min at room temperature. The embryos were then rinsed in 0.1M 
triethanolamine followed by 0.1M triethanolamine supplement with 0.25% acetic 
anhydride two times. After re-fixed, washed extensively with PTw, embryos were 
prehybridized in hybridization buffer (50% formamide, 5x SSC, 0.2mg/ml tRNA, 0.1% 
tween-20, 0.1%CHAPS, 1x Denhardt’s, 10mM EDTA and 0.1mg/ml heparin) at 60°C for 
6 hours. After prehybridization, the embryos were incubated with 0.5µg/ml of 
digoxygenin-labeled probes at 60°C overnight followed by serial wash in  2 x SSC and  
high-stringency wash in 0.2 x SSC to get ride of nonspecific probe binding. Embryos was 
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then incubated with 1% blocking reagent (Roche) for  1 hour followed by incubation with  
1:3000 alkaline phosphatase conjugated anti-digoxygenin antibody in 4 °C overnight. 
After multiple washes with excess MAB (100mM Maleic Acid, 150mM NaCl ) at room 
temperature over a period of at least 6 hr, embryos were equilibrated with phosphatase 
buffer( 100 mM Tris, pH 9.5, 0.1M NaCl, 50 mM MgCI2, 2 mM levamisole and 0.1% 
Tween-20) and then treated  with nitro blue tetrazolium and 5-bromo-4-chloro-3- indolyl 
phosphate substrates (NBT/BCIP).Color development was allowed to proceed in the dark 
(usually for 1 hr or less) and was stopped by washing with MAB. Embryos were then 
fixed in Bouin’s solution (70% saturated picric acid, 5% glacial acetic acid and 25% 
formalin) overnight. After that, the pigment of embryos were bleached in bleaching buffer 
(1% H2O2, 5% formamide and 0.5 x SSC) on top of light box for 2 hours.  
 
2.12.  Histological analysis  
Xenopus embryos at stage 45 were fixed in 10% formalin overnight, then 
dehydrated in gradual alcohol from 50% to 100%, cleared by xylene and impregnated in 
paraffin at 60°C. The embryos were sectioned at 4-µm thickness and the serial sections 
pass through heart region were collected for hematoxylin and eosin (HE) Staining.  Slides 
of paraffin section were deparaffinized and rehydrated in gradual alcohol from 100% to 
50%, then rinsed in water and stained in hematoxylin for 1 min.  After washed well in tap 
water, the slides were stained with eosin for 10 sec and rinsed with tap water, then 
dehydrated with alcohol, cleared with xylene, and mounted with polymount mounting 
media. 
 
2.13. Transmission electron microscopy 
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Hearts and somites were removed from Xenopus embryos at stage 45, fixed in 
2.5% glutaraldehyde, rinsed in 0.1 M phosphate-buffered saline (PBS), and postfixed in 
1% osmium tetroxide for 1 h. The sample was rinsed in phosphate buffer, dehydrated in 
ethanol, and embedded in resin. Semithin sections (0.5 µm) and ultrathin sections (90 to 
95 nm) were cut with a glass knife. Semithin sections were stained with toluidine blue and 
examined with a Zeiss microscope. Ultrathin sections were stained with uranyl acetate and 
lead citrate and examined with a Jeol JEM1010 transmission electron microscope.  
 
2.14. In vitro transcription and translation 
XGRIM-19 protein was synthesized using TnT quick coupled 
transcription/translation system (Promega). 0.5 µg of pcDNA-XGRIM-19 plasmid was 
incubated with 40µl of TnT T7 Quick master mix and 20 µM methionine in the presence 
or absence of 4-20 ng/µl morpholino oligonucleotides (MOs). Translation was carried out 
at 30°C for 90 min. The translation products were separated by 12% SDS PAGE gel and 
analyzed by Western blotting. 
 
2.15. Si RNA 
Knockdowns by siRNA were performed using pSUPER.neo (OligoEngine) 
following the manufacturer’s instruction. The following sequences were used:  
hGRIM-19, 5’-GGCACTGGAGCATAATGAA-3’;  
NDUFS3: 5’-TGTGGATCCTAGACAGCGC-3’  
Control, 5’- TCAGTTCCGTAACGTAGCA -3’.  
The plasmids were then transfected into HeLa cells by Lipofectamine 2000. 
Monoclonal stable cell lines were established by selected in 200µg/ml G418 for 3 weeks. 
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Single clones were picked up and expanded, and the knockdown efficiency was examined 
by Western blotting. Four clones displaying efficient knockdown of GRIM-19 or 
NDUFS3 were pooled and used for further experiments. The same methods were used to 
make knockdown cell lines in Jurkat except 800 µg/ml of G418 was used for selection.  
 
2.16. Western blotting 
Cells were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.2, 1% 
deoxycholic acid, 1% Triton X-100, 0.25 mM EDTA, pH 8.0, containing protease and 
phosphatase inhibitors 5 µg/ml leupeptin, 5 µg/ml aprotinin, 1 µg/ml pepstatin A, 1 mM 
PMSF, 5 mM NaF, and 100 µM sodium orthovanadate). The protein concentrations were 
estimated by using the Bio-Rad protein assay reagent (Bio-Rad Laboratories) according to 
the manufacturer’s instructions, and reading the absorbance at 595 nm wavelength in a 
spectrophotometer. For total cell Western, an aliquot of total cell lysates was boiled in 2X 
Laemmlli buffer, followed by a similar procedure as described above. For Western 
immunoblotting, the blots were blocked 1 h at room temperature in either 1% BSA or 5% 
skim milk, in PBS containing 0.1% Tween-20, with gentle shaking. Respective primary 
antibodies were incubated with the blots at a dilution recommended by the manufacturer, 
in PBS containing either 1% BSA and 0.1% Tween-20 or 1% skim milk and 0.1% Tween-
20, for 1 h at room temperature with gentle shaking. Nonspecific binding of the antibodies 
was washed with 0.2% Tween-20 in PBS for six times at 5 min intervals. Horseradish 
peroxidase (HRPO) conjugated secondary antibodies were diluted in PBS containing 
either 1% BSA and 0.1% Tween-20 or 1% skim milk and 0.1% Tween-20, for 1 h at room 
temperature with gentle shaking. Again, nonspecific binding of the antibodies was washed 
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in the same manner as described above. Protein bands were detected by 
chemiluminescence method using the ECL kit from Amersham Pharmacia Biotech. 
 
2.17. Intracellular calcium measurement 
3 × 106 HeLa cells were washed and incubated in sample medium containing 2.5 
µM Fura-2/AM and 0.1% F-127 at 37°C for 30 min followed by washing and de-
esterification in sample medium for 30 min.  The cells were washed, and resuspended in 
the sample medium, and transferred into a stirred, temperature-controlled (37°C) cuvette 
placed in a Shimadzu RF-5301PC spectrofluorophotometer (Shimadzu). Data were 
collected using dual-wavelength excitation at 340 and 380 nm and an emission 
wavelength of 510 nm at a frequency of 1 Hz. The sample media contained 25 mM Hepes, 
pH 7.4, 140 mM NaCl, 2 mM CaCl2, 5 mM KCl, and 1 mM MgCl2, in the presence of 5 
mM D-Glucose or 2 mM pyruvate. 
 
2.18. Luciferase reporter assay 
For embryos injected with 20 ng of MOs at stage 1, two cells of each embryo at 
stage 2 were co-injected with luciferase reporter construct pNFAT-TA-luc (40 
pg/blastomere), purchased from BD Bioscience, and Renilla control plasmid (20 
pg/blastomere). For each sample, three pools containing four embryos each were collected 
at indicated stages and homogenized in passive lysis buffer (Promega), and dual-luciferase 
reporter assays were performed as described previously (25). The cultured cells were 
transfected using Lipofectamime 2000. For Jurkat cells, after transfection with pNFAT-
TA-luc and Renilla control plasmids for 16 h, 2 µg/ml of anti-CD3 and 1 µg/ml of anti-
CD28 antibodies or 10 ng/ml PMA and 1 µM ionomycin were added to the medium and 
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incubated for 8 h before harvesting for luciferase assay. P19 cells were transfected with 
luciferase reporter, the wild-type NFATc4 or CA-NFATc4, and Renilla control plasmids. 
After transfection for 6 h, cells were treated with 20 nM of RA or left untreated, cultured 
for 72 h, and harvested to measure luciferase and renilla activity. 
 
2.19. Reverse Transcriptase- polymerase chain reaction (RT-PCR) 
                    Table 1     Primer sequences for RT-PCR 



























































Total RNA was isolated from Xenopus embryos or culture cells using Trizol reagent 
(Invitogen) according to the manufacturer’s guide. The embryos or cells were 
homogenized in Trizol reagent, mixed with chloroform and subsequentially centrifuged to 
separate RNA. The RNA from the aqueous phase was then precipitated by isopropyl 
alcohol and washed by 70% alcohol. RT-PCR was performed using One-step RT-PCR kit 
(Qiagen). 0.3-0.5 µg total RNA was mixed with 10 µl 5X reaction buffer, 10 µl Q 
solution, 0.2 mM dNTP, 1 µM forward and reverse primers and 0.5 µl enzyme mix.  The 
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reaction mixes were incubated in 50oC for 30 min and then heated up to 95oC for 15 min, 
followed by 20-30 cycles of denaturation at 95oC for 30 sec, annealing at 50-65oC for 30 
sec, and extension at 72oC for 1 min. Primers for RT-PCR are listed in Table 1. 
 
2.20.  Electrophoretic mobility shift assay (EMSA) 
HeLa cells were transfected with pCDNA3-CA-NFATc4 or empty pCDNA3 
vector for 24 hours. Nuclear protein from either untransfected or transfected HeLa cells 
was harvested for EMSA.  The EMSA was performed using probes containing NFAT 
binding elements from IL-2 gene (IL-2) or Nkx2.5 promoter (m1176-m9513). For 
supershift or competition experiments, NFATc4 or GP130 antibodies or molar excess of 
cold oligonucleotides were incubated with the nuclear extracts prior to the addition of 
radiolabeled   probes. The double-stranded DNA probes using in this study are: 
IL-2:        5’-CGCCCAAAGAGGAAAATTTGTTTCATA-3’; 
IL2 mut:  5’-CGCCCAAAGCTTAAAATTTGTTTCATA-3’;  
m9513:   5’- GCCCGACAGGAAACTCGGAGCTATTTAAAAAG -3’;  
m9460:  5’- TTTATCTTCCCCGGAGGAAAACTTCTTGCCGA -3’;  
m3073:  5’- GAAACCCCCATCTGTTTCCCTGGCGCGGGCCA -3’;  
m2910:   5’- GCGGCTGATTGCAGGAAAGGGGGGGCGCTC -3’;  
m 1910:  5’- TGTGGCAAGGGAGGAAAACAAAACAAAAC -3’;  
m1176:  5’- AGATTACAGCAGGAAAAAGTCCCACTCTGT -3’.  
Underlines are wild type or mutated core NFAT binding sites. 
 
2.21.  Mitochondrial complex I oxidative phosphorylation assay. 
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Embryos at stage 28 were collected and homogenized in the mitochondrial 
isolation buffer (MIB) containing 10 mM Tris-HCl (pH 7.4), 10 mM HEPES, 0.5 mM 
EDTA, 250 mM sucrose, 10 mg of bovine serum albumin per ml, 12% Percoll, and 
proteinase inhibitor cocktail (Roche). The raw lysate was centrifuged at 1,000g for 5 min 
to remove nucleus. Supernatant was collected and centrifuged at 14,000 × g for 5 min. The 
pellet containing mitochondria was resuspended in solution containing 750 mM 6-
aminocarproic acid, 50 mM bis-Tris (pH 7.0), and 5 µl of 10% dodecylmaltoside. The 
mitochondrial lysate was centrifuged and the supernatant was used for further assays. 
Separation of mitochondrial complexes was performed on 5%-18% polyacrylamide 
gradient Blue-Native-PAGE. In-gel colorimetric reactions for oxidative phosphorylation 
of complex I and complex II were performed as described previously (19). Briefly, 
following BN-PAGE, the gels were rinsed with distilled water and then equilibrated in 
complex I reaction buffer (0.1 M Tris-HCl [pH 7.4]) for 10 min. The gels were 
subsequently incubated in fresh complex I reaction buffer plus 0.2 mM NADH as 
substrate and 0.2% nitroblue tetrazolium for 30 min. After this, the same BN gel was 
equilibrated with complex II reaction buffer (50 mM KH2PO4, 0.1 mM ATP, 4.5 mM 
EDTA [pH 7.4]) for 10 min, followed by incubation of the gel with fresh complex II 
reaction buffer with 10 mM succinate as substrate, 0.2% nitroblue tetrazolium, and 0.2 
mM phenazine methosulfate for 30 min. The gels were destained overnight in 45% 
methanol and 10% acetic acid.  
 
2.22. Whole-mount in situ TUNEL staining  
The whole-mount TUNEL staining protocol was performed using in situ cell death 
detection kit (Roche) with some modifications. Briefly, after injected with MOs at stage 1, 
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albino embryos was fixed in MEMFA at indicated stages, and stored in methanol at -20°C. 
Embryos were rehydrated in PBT; washed in PBS, then treat with 10ug /ml proteinase K 5 
min. After heated in 100°C for 4 min to inactivate PK, embryos were incubated with 
TUNEL reaction mixture overnight at RT. The reaction was terminated in PBS/1 mM 
EDTA, followed by washes in PBS. Detection was carried out by blocking embryos in 
PBT + 20% goat serum, followed by incubation with anti-FITC antibody coupled to 
alkaline phosphatase. Embryos were extensively washed in PBS and staining developed 
using nitro blue tetrazolium and 5-bromo-4-chloro-3- indolyl phosphate substrates. 
2.23. Statistical Analysis.  
The results were analyzed with the Chi-Square test or Mann-Whitney test. A p 
value of 0.05 was considered to be significant. 
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3.1. Introduction 
 
Mitochondria are double-membrane enclosed organelles found in cytoplasm of 
eukaryotic cells. It is cell’s power producer which convert energy to ATP used by various 
cellular processes. As mentioned in Chapter 1, majority of ATP are produced through 
oxidative phosphorylation by the mitochondrial respiratory chain (MRC) localized in the 
inner membrane of the mitochondria. MRC consists of five multi-subunit complexes 
(complexes I-V). Complex I and II catalyze the reduction of substrates NADH and 
FADH2 respectively, and transfer two electrons from the substrates to molecular oxygen 
through Complex III and IV. Simultaneously, complex I, III and IV pump protons across 
the inner mitochondrial membrane to generate a proton gradient. The electrochemical 
energy of this gradient is then used to drive ATP synthesis by complex V (Schultz and 
Chan, 2001; Hirst et al., 2003).   
Besides acting as a power house, mitochondria have been found to be involved in 
diverse bioprocesses and signaling pathways through a so-called retrograde 
communication (Butow and Avadhani, 2004). The intracellular calcium signaling is the 
one of these pathways which is responsible for mitochondrial activities.  It has been found 
that mitochondria are mainly localized in perinuclear region in close contact with ER, an 
intracellular calcium pool. Mitochondria function as a calcium buffer to intake the calcium 
released from the adjacent ER upon stimulation. The calcium is then released out from 
mitochondria to cytoplasm to increase the duration of calcium pulse. Recently, the 
mitochondrial calcium intake has been found to be coupled with energy synthesis. 
Mitochondrial Ca2+ accumulation promotes rate of OXPHOS and increases ATP synthesis 
through activation of several mitochondrial enzymes (Hajnoczky et al., 1995; McCormack 
and Denton, 1993).  An intracellular calcium release is always followed by an OXPHOS 
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transient increase during the sperm triggered calcium oscillation in mouse egg (Dumollard 
et al., 2004). This calcium triggered ATP production could be important in maintaining 
calcium homeostasis and mobilization since SERCA, a Ca2+ ATPase on the ER, needs 
ATP to refill ER calcium store. Disruption of the MRC function by MRC inhibitors or 
uncoupers causes calcium leaking from ER, which is probably due to a shortage of ATP 
supply for SERCA, and results in a high cytosolic static calcium level. The increasing of 
static calcium activates several calcium dependent enzymes such as PKC and CamKIV 
and triggers the downstream gene expression such as CEBP, ATF2 and CHOP (Arnould et 
al., 2002; Biswas et al., 1999). Unlike CamK and PKC, the calcium-calcineurin-NFAT 
pathway can not be activated by increasing static calcium but needs a high frequency of 
calcium spikes and subsequent calcium release induced calcium current (ICRAC) to 
switch on. It has been found that depletion of mitochondrial membrane potential inhibits 
InsP3 triggered intracellular calcium release. Sperm triggered calcium oscillation is also 
disrupted by withdrawing energetical substrates in mouse egg. Furthermore, mitochondria 
have been shown to extend ICRAC through inhibition of Ca2+ dependent slow inactivation 
of Ca2+ influx (Parekh, 2003). Thus, disruption of MRC function could impair intracellular 
calcium transient which is important for activation of NFAT signaling. However, it lacks 
direct evidence that MRC functions in regulating NFAT signaling. Transcription factor 
NFAT family contributes to development of several organ systems including the heart 
(Crabtree and Olson, 2002). It is also unknown if impairing MRC activity could have any 
effect on the NFAT mediated cardiac development.  
Disruption of mitochondrial function results in mitochondrial diseases in human. 
60% of mitochondrial diseases are due to MRC defect. MRC contains 5 protein complexes 
which are made up of more than 90 subunits. Only 13 subunits are encoded by mtDNA, 
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whereas the others are encoded by nuclear DNA. Mutation of these subunit genes impairs 
the function of MRC and results in multi-system disorders including encephalopathy, 
myopathy and cardiomyopathy from infant to adulthood.  Beside these clinical 
phenotypes, animal experiments suggest that severe MRC defects may affect embryonic 
development. Homozygous knockout of mitochondrial transcription factor A (Tfam), a 
gene necessary for transcription of all 13 mitochondrial DNA (mtDNA)-encoded MRC 
subunits, causes embryonic lethality prior to E10.5 with heart defect in mice (Larsson et 
al., 1998). Depletion of GRIM-19 , a new identified subunit of MRC complex 1 in mice 
also causes early embryonic lethality before embryonic day 9.5 (Huang et al., 2004). 
These data suggest that MRC plays a critical role in the early embryonic development. 
However, how MRC regulates early embryonic development is largely unknown. 
Studying the role of MRC in embryo development will help us to understand the 
pathogenesis of human MRC disease and expand our view of mitochondria controlled 
signal pathways which may be involved in this process.  In this part of the thesis, I 
investigated the role of MRC in the early embryonic development, especially 
cardiaogenesis using GRIM-19 knocked down Xenopus laevis as a model, and tried to 
delineate the role of the NFAT pathway in the MRC mediated cardiogenesis.    
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3.2.1. Cloning and expression pattern of XGRIM-19 in Xenopus laevis.  
Two clones showing identical nucleotide sequence were isolated from Xenopus 
laevis oocyte library and named as XGRIM-19. Similar to the other species, XGRIM-19 
encodes an open reading frame containing 144 amino acids, and displays 92%, 72% and 
72% amino acid identity to Xenopus tropicalis, mouse, and human GRIM-19, respectively 
(Figure 3.1). Expression pattern of XGRIM-19 during embryogenesis was examined by 
whole-mount in situ hybridization (Figure 3.2A). It was expressed in the animal cap and 
marginal zone of embryos, representing the future ectoderm and mesoderm respectively, 
at stage 10, the gastrulation stage. During organogenesis, XGRIM-19 is specifically 
expressed in tissues with high energy expenditure such as neural, eye, skeletal muscle, and 
heart tissue. This is consistent with the function of GRIM-19 in mitochondrial respiration 
chain. GRIM-19 mRNA synthesis was very low in the blastula stage (stages 5-9) and 
increased gradually after gastrulation (stages 11-40) with high levels at stages 30 and 40 
(Figure 3.2B). However, the XGRIM-19 protein can be detected from stages 5 to 15, 
which probably represents the maternal XGRIM-19 protein. XGRIM-19 protein level also 
increased from stages 20 to 40 (Figure 3.2C). These results may reflect a minimum 
requirement for the mitochondrial OXPHOS at the early embryogenesis stage and an 
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Figure 3.1  Comparison of the amino acid sequence of GRIM-19 between Xenopus 
laevis,   Xenopus tropicalis, mouse, and human.  
 















Figure 3.2A  In situ hybridization of XGRIM-19 in Xenopus embryos.  
 
XGRIM-19 mRNA was detected in ectoderm and mesoderm of embryos at stage 11 (i). 
animal cap and marginal zone are indicated.  During organogenesis, XGRIM-19 mRNA 
was strongly expressed in the central nervous system (CNS) and eyes at stage 25 (ii), 
kidney, skeletal and heart muscles (iv) at stage 35 as indicated. 
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3.2.2. Knockdown of XGRIM-19 impairs MRC complex I activity in Xenopus 
embryos. 
To investigate the role of mitochondrial OXPHOS in early embryonic 
development, we knocked down XGRIM-19 with two specific antisense morpholinos 
(MO) to block its translation in Xenopus embryos. MO1 targets 5’ UTR of XGRIM-19 
mRNA and MO2 targets the sequence from the start codon (first ATG). Both MO1 and 
MO2 inhibited translation of XGRIM-19 mRNA in the in vitro translation experiment, 
whereas the control MO (designated as C), consisting of a similar nucleotide sequence to 
GRIM-19
28 & 18 S RNA











Figure 3.2(B and C) XGRIM-19 mRNA and protein expression pattern during embryo 
development. 
 
(B) XGRIM-19 mRNA in the different developmental stages was detected by RT-PCR 
with 28S and 18S RNA as loading controls.  (C) XGRIM-19 protein level was detected by 
Western blot analysis (WB) using anti-mouse GRIM-19 antibody The blot was re-probed 
with anti-actin as a control. 
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MO1 but with four point mutations, had no effect (Figure 3.3A). Both MO1 and MO2 
showed similar phenotypes in vivo, but MO1 worked more efficiently than MO2 (data not 
shown), and was used in most of our experiments. After MO1 injection at stage 1 of the 
Xenopus embryos, decrease of GRIM-19 protein was observed at stage 15 (data not 
shown), and was almost completely knocked down at stage 28 and 45 (Figure 3.3B, lanes 
2 and 5).  
 
Morpholino - C       MO 1     MO 2
A
1     2      3     4      5      6














Figure 3.3  Knockdown efficiency of XGRIM-19 and its effect on the complex I activity. 
  
(A) XGRIM-19 MOs inhibit translation of XGRIM-19 mRNA in vitro. pcDNA3-XGRIM-
19 construct was transcribed and translated in vitro in the presence of  XGRIM-19  MO1, 
MO2, or the control MO (C) at indicated concentrations. (B) XGRIM-19 MO1 inhibits 
XGRIM-19 protein expression in vivo. Xenopus embryos were injected with indicated 
MOs and mRNA. Total lysates of embryos were harvested for WB.  
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Amphibian heart precursor cells are derived from dorsal mesoderm. Human 
GRIM-19 (hG19) mRNA was injected to the XGRIM-19 KD embryos in two dorsal cells 
at stage 3 for rescue purpose. GRIM-19 protein levels at stage 28, were partially restored 
in the human GRIM-19-rescued group, demonstrating the uptake and expression of human 
GRIM-19 mRNA. However, the GRIM-19 protein level did not show increase at stage 45, 
possibly due to eventual degradation of human GRIM-19 mRNA (shown in Figure 3.3B, 
lanes 3 and 6). 
Since GRIM-19 is an important subunit of complex1, the knockdown efficiency of 
MO1 in embryos was further evaluated by observing its effect on complex I enzymatic 
activity using blue native polyacrylamide gel electrophoresis (BN-PAGE) assay. At stage 
28, ~80% of the complex I activity was inhibited in the XGRIM-19 KD embryos in 
comparison with the control embryos, but the complex II activity was largely unaffected 
















Figure 3.4  Knockdown of GRIM-19 impairs complex I activity.  
 
(A) The representative  activities of complex I and complex II were assayed in the control 
(C) and XGRIM-19 KD (MO1) embryos at stage 28 by in gel oxidative phosphorylation 
assay. (B) The relative activity of complex I to complex II was calculated after band 
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3.2.3. Knockdown of XGRIM-19 causes heart defect in Xenopus embryos.  
After injection with MO1, the embryos exhibited retarded growth indicated by 
smaller size with a shorter anterior axis (Figure 3.5). The hindbrain, eyes, and skeletal 
muscles were developed but with abnormal morphology, which are very similar to the 
multi-system syndromes of human mitochondrial disease (see Figure 3.6A). GRIM-19 KD 




Figure 3.5 General morphology and cardiovascular formation in XGRIM-19 KD 
embryos.  
 
Ventral view of stage 45 embryos injected with indicated MOs and human GRIM-19 
mRNA is presented on left panel. The light microscope views of hearts (black arrow) and 
blood vessels (red arrow) from control (upper), XGRIM-19 KD (middle) and XGRIM-19 
KD with HG19 mRNA rescue (bottom) embryos are presented on right panel.  
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Figure 3.6 Knockdown of XGRIM-19 causes multi-system disorder in Xenopus embryos.   
(A)Histological analysis of morphology of the hind brain, the eye, and skeletal muscle in 
control MO and XGRIM-19 MO1 injected embryos at stage 45. (B) Whole-mount in situ 
TUNEL staining of control MO and XGRIM-19 KD embryos. Extensive apoptosis was 




Strikingly, the most severe defect occurred in the heart development. No heart 
formation was observed in more than 70% of the XGRIM-19 KD embryos (yellow bar in 
Figure 3.7A). Only about 20% of the XGRIM-19 KD embryos formed hearts, but had 
abnormal morphology and much smaller size (pink bar in Figure 3.7A). In these embryos, 
although sometimes a beating nub was visible in the pericardial cavity (Figure 3.5 middle 
right panel), the defect was obvious in comparison to the heart seen in the control embryos 
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(Figure 3.5 upper right panel). There were few or no circulating blood cells in heart 
chambers or blood vessels observed under the microscope in these GRIM-19 KD embryos 
(Figure 3.5 red arrow). Histological study further revealed that in comparison to the well-
developed hearts with intact ventricles and atria at stage 45 of the control embryos (Figure 
3.7B), the hearts of the XGRIM-19 KD embryos failed to undergo looping and retained 
their linear conformation without atrial and ventricular chamber formation, indicating that 
these embryos failed to develop beyond a very early stage in heart formation (Figure 
3.7C). To confirm that the phenotype is due to knockdown of the XGRIM-19, human 
GRIM-19 (hG19) mRNA was injected to the XGRIM-19 KD embryos in two dorsal cells 
at stage 3. The Xenopus specific MO1 should have no effect on the human GRIM-19 
mRNA owing to the sequence divergence between two species. Injection with hG19 
mRNA rescued more than 50% of embryos with heart defects and also restored blood 
circulation. However, enlarged hearts were also observed in most of the rescued embryos 
(light blue bar in Figure 3.7A and Figure 3.5 bottom right panel). Histological analysis 
confirmed that human GRIM-19 restored the heart structure which was accompanied by 
heart enlargement (Figure 3.7D). This was mainly due to a dilation of atria (black arrow) 
and a defect of atrioventricular valves (circle). In contrast, the control embryos displayed 
intact atrioventricular valves (Figure 3.7B). GRIM-19 protein levels at stage 28, were 
partially restored in the human GRIM-19-rescued group, demonstrating the uptake and 
expression of human GRIM-19 mRNA. However, the GRIM-19 protein level did not show 
increase at stage 45, possibly due to eventual degradation of human GRIM-19 mRNA 
(shown in Figure 3.3B, lanes 3 and 6).  
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Figure 3.7 Knockdown of XGRIM-19 causes heart defect in Xenopus embryos.  
(A) Statistical data showing heart defects in control, XGRIM-19 KD, XGRIM-19 KD with 
human GRIM-19 mRNA rescue. Numbers (n) of treated embryos are indicated. Heart 
development was examined under the microscope at stage 45 and grouped as ‘normal’, 
‘abnormal’, ‘no heart’, or ‘dilated’, indicated by different colors. The percentage of 
embryos displaying different phenotypes is presented as bars (**, P<0.01). (B-D) 
Histological analysis of heart morphology in control (B), XGRIM-19 MO1 injected (C), 
and human GRIM-19 mRNA- rescued (D) embryos at stage 45.  The numbers of embryos 
examined in each group were 4, 4 and 3, respectively. Transverse sections of the heart 
were examined and only one set of embryos is represented. Black arrows indicate the 
atria, green arrows indicate ventricles, arrowhead indicates heart tube, and circles indicate 































































                                                                                                                                Chapter 3 
 
                                                                                                                                             73 
To further confirm that the heart deficiency in XGRIM-19 KD embryos was due to 
a depletion of MRC complex I, an inhibitor of complex I, rotenone, was incubated with 
the wild-type Xenopus embryos from stage 12, a point after gastrulation and onset of 
organogenesis. This treatment led to a heart deficiency which is almost identical to the 
GRIM-19 knockdown embryos with 16% embryos exhibiting abnormal heart and 84% 
having no heart. In comparison, used as solvent of rotenone, DMSO alone did not resulted 
in heart deficiency (Figure 3.8). These results confirm the heart defects resulted from 
complex I deficiency.  
 
Figure 3.8 inhibition of complex I activity causes heart defect in Xenopus embryos.  
Statistical data showing heart defects in 0.5µM rotenone or DMSO-treated wild-type 
Xenopus embryos at stage 45. The percentage of embryos displaying heart phenotypes of 
normal, abnormal, and no heart are indicated as bars and numbers of the embryos are 
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3.2.4. Knockdown of XGRIM-19 down-regulates cardiac gene expression and NFAT 
activity.  
The effect of XGRIM-19 in cardiogenesis was further investigated by examining 
expression of several cardiac differentiation markers by whole-mount in situ 
hybridization. As shown in Figure 3.9, decreased expression levels of Nkx2.5, myosin 
light chain 2 (MLC2), and cardiac actin (CA, white arrows) were observed in cardiac 
tissue of the embryos with depleted XGRIM-19 at stage 28. The cardiac actin was also 
expressed in somites, where expression was unaffected by knockdown of XGRIM-19 
(black arrow heads). However, expression of the bone morphogenetic protein 4 (BMP4) 
and GATA binding protein 4 (GATA 4), which are also implicated in the initiation of 
heart development, remained unaffected in the cardiac region. The statistical data are 









Table 2. The statistical data showing expression of heart specific genes (Nkx2.5, MLC2 , 
cardiac actin, BMP4 and GATA4) at different stages in the embryos injected with either 
control MO or XGRIM-19 MO1. -: no expression, +: low expression, ++: high expression, 
n: total number of injected embryos. (**, P<0.01 and *, P<0.05 for the difference of genes 
expression between control and XGRIM-19 KD embryos). 
Table 2
Specific gene expression in control and XGRIM-19 KD embryos
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Figure 3.9 Depletion of XGRIM-19 down-regulates expression of several cardiac genes.  
 
Whole-mount in situ hybridization showing the expression of Nkx2.5, MLC2, cardiac 
actin, BMP4 and GATA4 in the control (left panels) or the XGRIM-19 KD (right panels) 
embryos at stages 28 (lateral views). The cardiac actin expression in the heart region is 
indicated by white arrows and in somite by black arrow heads. 
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Consistent with the in situ hybridization results, RT-PCR also showed decreased 
expression of Nkx2.5 at stage 23 and 28, and MLC2 at stage 28 in XGRIM-19 KD 
embryos. The blood cell marker T3 globin was also decreased. On the other hand, BMP4 
and GATA4 were not affected. FLK-1, a blood vessel marker, was slightly increased in 
the XGRIM-19 KD embryos at stage 28. As a control, expression of ornithine 
decarboxylase (ODC) remained the same in both control and XGRIM-19 KD embryos 
(Figure 3.10). These results suggest that only specific pathway(s) and genes are affected 













Figure 3.10 Depletion of XGRIM-19 affects expression of specific cardiovascular genes 
during different embryonic stage.  
 
Total RNA of embryos injected with control MO (C) or XGRIM-19 MO1 were harvested 
at different embryonic stages. Various gene expression levels are detected by RT-PCR. 
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The transcription factor NFAT family contributes to the development of the 
immune, heart, vasculature, and nervous systems. The mouse NFAT family comprises 
four cytosolic proteins (NFATc1-4) and a constitutive nuclear phosphoprotein (NFAT5). 
All five NFAT homologues are found in GenBank database of Xenopus tropicalis, but 
only one that is homologous to the human NFATc3 has been cloned in Xenopus laevis 
(Saneyoshi et al., 2002). We examined the expression level of XNFAT and did not find 
any obvious change in the XGRIM-19 KD embryos (Figure 3.10). We then tested the 
activity of endogenous XNFAT(s) by injecting a reporter plasmid, pNFAT-TA-luc, 
containing an interleukin (IL)-2 promoter, into the Xenopus embryos. The results showed 
that in comparison to the control embryos, the NFAT activity in the XGRIM-19 KD 



















Figure 3.11 Depletion of XGRIM-19 compromises NFAT activity.  
 
Embryos injected with control or MO1 together with pNFAT-TA-luc reporter and control 
Renilla luciferease construct were harvested from different stages (as indicated) and dual 
luciferase assay was performed. The average levels of luciferase activity are shown in the 
graph with error bars representing the standard deviation of the means from three 
experiments.  
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3.2.5. Constitutively activated NFATc4 rescues the heart defect in XGRIM-19 KD 
embryos.  
Our results suggested that the NFAT activity is affected by down-regulation of 
XGRIM-19. We next examined whether an active form of NFAT can rescue the heart 
defects caused by XGRIM-19 KD. We constructed constitutively active NFATc4 
(designated as CA-NFATc4) by deleting the NH2-terminal calcium-calcineurin-dependent 
regulatory domain, which confers the mutant with constitutive nuclear translocation and 
transcriptional ability. We first measured its transcriptional activity in mammalian cells by 
luciferase assays. Activity of the wild-type NFATc4 which was low in unstimulated cells 
could be increased by ionomycin, a calcium ionophore that triggers intracellular Ca2+ 
increase. In contrast, CA-NFATc4 showed constitutive activity in the absence of 










Figure 3.12 Comparison of NFATc4 and CA-NFATc4 activity in MCF-7 cells.   
 
MCF-7 cells were co-transfected with the pNFAT-TA-luc construct and either pcDNA3-
NFATc4 or pcDNA3-CA-NFATc4. Cells were or treated with ionomycin. Luciferase 
assay was performed in triplicate. The average luciferase activity from three independent 
experiments is shown with error bars representing the standard deviation of the means. 
NFATc4
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Figure 3.13 CA-NFATc4 partially rescues the heart defect in XGRIM-19 KD embryos.  
 
(A-D) Light micrograph of general shape and heart morphology in control (A), XGRIM-
19 MO1 injected (B), and CA-NFATc4 mRNA- rescued (C) embryos at stage 45. High 
magnified pictures on heart region are presented on the bottom right corner of each 
figures. Inside the circles are hearts. (D) A fluorescent dye FDA was co-injected with CA-
NFATc4 mRNA to monitor the correct delivery of mRNA into dorsal region. (E) 
Statistical data showing heart phenotyps in embryos injected with control MO, XGRIM-
19 MO1 or XGRIM-19 MO1 and CA-NFATc4 mRNA. The percentage of embryos 
displaying heart phenotypes of normal, abnormal, and no heart are indicated as bars and 
numbers of the embryos are shown on top (n). (**, P<0.01). (F) GRIM-19, NFATc4, 
VDAC, HSP60 and actin gene expressions in stage 28 embryos were analyzed by Western 
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We subsequently injected CA-NFATc4 mRNA into 2 dorsal cells of Xenopus 
embryos at stage 3 after injecting MOs at stage 1. Less than 20% of the XGRIM-19 KD 
embryos displayed normal heart development, but injection with CA-NFATc4 mRNA 
increased this number to more than 50% (Figure 3.13E, purple bars). Conversely, embryos 
with severe heart defects decreased from 60% to 18% (Figure 3.13E, yellow bars). In 
addition, the development of atria and ventricles and functional blood vasculature were 
visible in most of the CA-NFATc4-rescued embryos (Figure 3.13C) in comparison with 
the defective GRIM-19 KD  embryos (Figure 3.13B). 
The efficiency of XGRIM-19 knockdown and the expression of CA-NFATc4 
protein were confirmed in the total lysate of stage 28 embryos (Figure 3.13F). Other 
mitochondrial proteins, such as voltage-dependent anion channel (VDAC) and heat shock 
protein Hsp60, used as controls, remained unaffected by either knockdown of XGRIM-19 
or expression of CA-NFATc4.    
 
3.2.6. NFATc4 rescues the defects of sarcomere formation in the heart muscles. 
NFAT was reported to regulate the myocardium formation by affecting sarcomeric protein 
expression (Schubert et al., 2003).  We checked the ultrastructure of heart and skeletal 
muscles in the control, XGRIM-19 KD, and CA-NFATc4-rescued embryos by electron 
microscopy. Heart muscles from control embryos exhibited normal sarcomere 
morphology with alternating rows of M and Z lines. In contrast, the sarcomere structure 
was disorganized and lacked clear M and Z lines in XGRIM-19 KD embryos, and in most 
cases, only scattered individual filaments were observed. However, injection with CA-
NFATc4 mRNA rescued the sarcomere defect in heart muscle of XGRIM-19 KD embryos 
(indicated by arrowheads in Figure 3.14, top panels). In the skeletal muscle of these 
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embryos, the sarcomere structure was retained although the amount was decreased 















Figure 3.14 Ultrastructure of heart and skeletal muscle from Xenopus embryos at stage 
45.  
 
Embryos injected by control MO, GRIM-19 MO, or GRIM-19 MO plus CA-NFAT were 
examined with transmission electron microscope. XGRIM-19 KD causes severely 
perturbed sarcomeres in heart (white arrowhead, top middle panel), and mitochondria 
proliferation (white arrow, second middle panel) as well as morphological abnormalities 
in skeletal muscle (white arrow, bottom middle panel). CA-NFATc4 can rescue the 
sarcomere formation in heart muscle (top right panel). Lipid droplet (LD) is commonly 
visible in XGRIM-19 KD muscles. Scale bars: 0.5 µM.  
 
Mitochondrial proliferation is a hallmark of mitochondrial myopathy (DiMauro et 
al., 1985). A dramatic increase of mitochondrial number was observed in both the 
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XGRIM-19 KD and CA-NFATc4-rescued embryos (white arrows in Figure 3.14, middle 
panels). The mitochondrial morphology was also abnormal. Some of them were rounded 
and swollen, with disorganized cristae inside the matrix (white arrows in Figure 3.14, 
bottom panels). In addition, we also observed lipid droplet (LD) formation, which is a 
common phenotype occurring in human mitochondrial diseases, in both heart and skeletal 
muscles of the XGRIM-19 KD and CA-NFATc4-rescued embryos (Figure 3.14), Taken 
together, these results indicate that CA-NFATc4 is able to rescue the defects in sarcomere 
formation in the heart muscles, but not the defects in mitochondria.   
 
3.2.7. Knockdown of XGRIM-19 or NDUFS3 impairs calcium mobilization and 
calcium-induced NFAT activity. 
 Intracellular calcium is the key regulator of NFAT. We examined whether 
depletion of MRC complex I disturbs the calcium signaling. MRC-deficient stable cell 
lines were created by knocking down GRIM-19 or NDUFS3, another complex I subunit, 
with siRNA in HeLa cells, and their effect on calcium regulation was examined by 
measuring changes in the intracellular calcium concentration, [Ca2+]i. Both the KD and 
control cells were grown in medium supplemented with glucose, and treated with pulsatile 
stimulation with 50 sec–application of InsP3-generating agonist, histamine (His). The 
control cells responded to His with a rapid and transient increase in [Ca2+]i (Figure 3.15, 
panel i, black arrows), which indicates Ca2+ amounts released from the intracellular stores, 
such as ER, via its receptors InsP3Rs. Following the rapid and transient Ca2+ spike, 
elevated levels of [Ca2+]i were  sustained, which probably represents the Ca2+ influx 
through CRAC on the PM triggered by ER Ca2+ depletion (Figure 3.15, panel i, green 
arrow). This persistent Ca2+ signal is necessary to activate NFAT (Timmerman et al., 
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1996). A second application of His resulted in another spike in Ca2+ concentrations at 
lower levels than the first, likely due to an intrinsic desensitization of His receptor. In 
contrast to the control cells, both GRIM-19 and NDUFS3 KD cells responded to the His 
stimulation poorly with a small [Ca2+]i elevation, which was insufficient for stimulation of 
a subsequent calcium entry as shown by a lack of the sustained elevation of [Ca2+]i (Figure 
3.15, panel ii and iii). Although in most cells, ATP is generated mainly by MRC via 
OXPHOS, it can also be produced by glycolysis. To ascertain the specificity of MRC-
produced ATP in the modulation of calcium signals, we checked the calcium mobilization 
without glucose but with pyruvate in the medium. The cells in such medium can produce 
ATP only through OXPHOS. The results showed an increase of [Ca2+]i triggered by His in 
the control cells, but to a lesser extent compared to the same cells grown in the presence of 
glucose. In addition, a lower induction of calcium influx was observed (Figure 3.15, panel 
iv, green arrow). Knockdown of GRIM-19 or NDUFS3 further decreased calcium release 
triggered by His (Figure 3.15, panel v and vi). In comparison, addition of oligomycin, 
which inhibits MRC complex V to prevent ATP synthesis, completely impaired the 
intracellular Ca2+ release and subsequent Ca2+ entry (Figure 3.15, panel vii). These results 
suggest that the ATP production from both OXPHOS and glycolysis is important for 
calcium mobilization. In contrast to tumor cell lines which use glycolysis as primary 
energy source, primary cells produce ATP mainly via mitochondrial 
OXPHOS(WARBURG, 1956). Thus, it is conceivable that MRC plays a more important 
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Figure 3.15 GRIM-19 knockdown compromises intracellular calcium mobilization. 
 
 GRIM-19 and NDUFS3 knockdown HeLa cells and control cells expressing non-specific 
siRNA were stimulated with 2.5 µM histamine (arrowhead) in sample medium containing 
5 mM glucose (panel i-iii) or 2 mM pyruvate (panel iv-vii). As a control, 25 µM 
oligomycin was added to medium to inhibit Complex V activity (panel vii). Calcium 
mobilization was measured using luminescence spectrophotometer. Fura 340/380 ratio 
indicates the change in [Ca2+]i. Green arrow indicates Ca2+ influx. 
 
To investigate whether the MRC deficiency can also affect the calcium-dependent 
NFAT activity, we knocked down either GRIM-19 or NDUFS3 in the human T-
lymphocyte line, Jurkat, and tested the endogenous NFAT activity. Anti-CD3 and CD28 
were used to activate T cell receptor (TCR)-NFAT signaling through induction of 
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and Bluestone, 2001). As shown in Figure 3.16, treatment of control Jurkat T cells with a 
combination of anti-CD3 and CD28 antibodies resulted in a significant increase of NFAT 
activity. However, the same treatment failed to raise NFAT activity to similar levels in the 
GRIM-19 or NDUFS3 knockdown cells. The calcium ionophore, ionomycin, activated 
NFAT signaling by direct induction of Ca2+ influx via alteration of the plasma membrane 
permeability for calcium, without requiring any Ca2+ release or subsequent influx in 
CRAC-dependent Ca2+ (Lewis, 2001). Treatment with ionomycin and phorbol 12 
myristate 13-acetate (PMA) drastically stimulated the NFAT activity in both control and 
KD cell lines, indicating that the defect was not due to loss of NFAT function per se in the 











Figure 3.16 GRIM-19 knockdown compromises NFAT activity. 
 
Control, GRIM-19 and NDUFS3 knockdown Jurkat cells were transiently transfected with 
pNFAT-TA-luc and stimulated with either anti-CD3/CD28 or ionomycin/PMA. 
Endogenous NFAT activity was analyzed by luciferase assay. The average luciferase 
activity from three independent experiments is shown with error bars representing the 
standard deviation of the means. 
NFAT activity in Jurkat cells
Control si GRIM-19         si NDUFS3  
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The knockdown efficiency was confirmed in HeLa and Jurkat cells (Figure 3.17). 
While GRIM-19- and NDUFS3-specific siRNAs down-regulated their respective protein 
levels, a complex II 70 kDa subunit was not affected, indicating the knockdown specificity.  
Together, these results reveal the role of MRC in regulating intracellular Ca2+ dynamics, 

















Figure 3.17 Knockdown efficiency of GRIM-19 and NDUFS3 in HeLa and Jurkat cells. 
 
Total lysates of control, GRIM-19 and NDUFS3 knockdown HeLa and Jurkat cells were 
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3.3. Discussion  
 
  The specific role of MRC in the control of embryonic development is difficult to 
dissect in mammalian systems because embryonic lethality occurs as a result of the MRC 
dysfunction. The amphibian embryo provides a useful model for studying the early 
embryonic developmental events, especially in heart development, since amphibians do 
not depend on cardiac function for much of their embryonic development (Mohun et al., 
2000). In Xenopus laevis, despite severe defects in heart formation and development, the 
embryos with XGRIM-19 knockdown remained alive for at least two weeks. Furthermore, 
in contrast to the GRIM-19 knockout in mice, knockdown of XGRIM-19 in Xenopus did 
not lead to early embryonic lethality, perhaps due to the presence of maternal XGRIM-19 
which is sufficient for the energy demand in the earlier stages of embryonic development. 
Therefore, this system allows us to study the MRC functions in the early embryonic 
development and establish the heart as one of the first major targets controlled by MRC in 
the organogenesis.  
In our experiments, injection of MO1 to the Xenopus eggs caused 90% inhibition 
in the GRIM-19 protein level which resulted in severe heart defects in most of the GRIM-
19 KD embryos. Human GRIM-19 mRNA rescued the defects in heart formation, but was 
accompanied by heart enlargement (Figure 3.5 and Figure 3.7). This could be due to the 
transient expression of human GRIM-19 mRNA which can only rescue partially. Thereby, 
it is possible that the degree of the MRC dysfunction determines the heart phenotype: the 
severe MRC dysfunction compromises the heart development, whereas the mild MRC 
dysfunction may provide low, but sufficient energy for the de novo heart formation, which 
is not enough to restore an entirely normal heart function and therefore resulted in the 
heart dilation. This phenotype is often observed in patients with MRC diseases, in which 
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the MRC function is reduced (Bindoff, 2003). On the other hand, due to critical function 
of the heart in mammalian embryonic development, severe heart defects may cause 
embryonic lethality, as seen in GRIM-19 or Tfam knockout mice, and therefore cannot be 
found in the MRC defective patients.  
In addition to the heart defect, knockdown of XGRIM-19 also causes less severe 
defects in the other tissues, such as brain, eyes, and muscles, although embryonic 
convergence and extension, and the general organogenesis in GRIM-19 KD embryos 
appear to be normal. GRIM-19 KD embryos exhibit extensive apoptosis in neural tissues 
but not in the muscles (Figure 3.6), suggesting that mitochondrial ATP production is 
crucial for maintaining cell survival in neural but not in muscular tissues. As for the 
muscular tissues, XGRIM-19 KD affects cardiac more severely than skeletal muscles 
(Figure 3.14). In agreement with this, GRIM-19 KD caused decrease of the cardiac actin 
expression only in the heart area, but not in the skeletal muscles (Figure 3.9). In heart 
development, MRC seems to affect mainly the intracellular calcium signaling pathway 
and Nkx2.5, but not the others such as BMP4 and GATA4 (Figure 3.9 and Figure 3.10). 
Finally, we also showed that NFAT alone is able to rescue the heart phenotype without 
simultaneously rescuing the MRC defects (Figure 3.13 and Figure 3.14). These results 
suggest that MRC controls early embryonic development by governing complex and 
specific signaling pathways which cannot be simply attributed to the general effect of 
shortage in energy supply. 
In this study, we have focused on how GRIM-19 regulates heart development in 
Xenopus. The heart development is initiated when the cardiac precursor cells in anterior 
lateral mesoderm becomes specified to a cardiac fate under induction of signals from 
adjacent tissues (Sater and Jacobson, 1989; Schneider and Mercola, 2001; Schultheiss et 
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al., 1995). The cardiac precursor cells then converge to the ventral midline and form the 
linear heart tube which undergo right looping and further conformation change to form a 
mature heart (Fishman and Chien, 1997; Olson and Srivastava, 1996). We found that the 
heart tube of the XGRIM-19 KD embryos failed to loop, and the constitutively activated 
mouse NFATc4 was able to rescue the heart development defect from this early stage 
(Figure 3.13). This suggests that in addition to effects on the later stage, such as formation 
of cardiac valve, septal, and myocardium, NFAT function is also necessary for the early 
heart development. This data agrees with previous finding that NFAT signaling is needed 
for cardiovascular development from E7.5 (onset of cardiogenesis) to E8.5 (looping of 
heart tube) in mouse (Bushdid et al., 2003; Graef et al., 2001).  More importantly, these 
data established a previously unknown link between the MRC and the activation of NFAT.  
Since NFAT activity is controlled via de-phosphorylation by calcium-dependent 
phosphatase calcineurin (Crabtree and Olson, 2002), it is possible that the calcium 
signaling could have been perturbed by knockdown of GRIM-19. Because of the technical 
difficulties, this could not be tested directly in whole embryos. To overcome this obstacle, 
GRIM-19- and NDUFS3-deficient HeLa cells were produced and used to measure 
intracellular calcium response. Both intracellular Ca2+ release and consequent CRAC were 
diminished in these two cells after stimulated by histamine (Figure 3.15). Furthermore, the 
Ca2+-dependent NFAT activity in Jurkat cells was also abrogated after depletion GRIM-19 
and NDUFS3 proteins by siRNA (Figure 3.16). These results demonstrate a crucial 
regulatory effect of MRC in calcium signaling, which is consistent with previous reports 
showing that MRC function and ATP production are essential for the sperm-triggered 
calcium oscillation and homeostasis (Dumollard et al., 2004; Liu et al., 2001).   
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We found that the knocked-down of GRIM-19 in Xenopus embryos resulted in 
failure of heart tube looping, which is phenotypically similar to Nkx2.5 knockout mice. In 
agree with this finding, we showed that depletion of GRIM19 inhibited the expression of 
Nkx2.5 in cardiac precursor cells. As a key cardiac transcriptional factor, Nkx2.5 regulates 
a number of cardiac gene expression including MLC2 and cardiac actin. Both MLC2 and 
cardiac actin decreased in cardiac region of GRIM-19 knocked-down embryos, suggesting 
the impairment of Nkx2.5 pathway in the MRC deficiency embryos. These findings raise a 
question: how does MRC affect Nkx2.5 pathway? The NFAT rescue experiments shed 
some clues on the above question. We found that NFAT activity was under control of 
MRC in a calcium dependent manner. Injection of constitutively active NFATc4 in 
GRIM-19 KD embryos rescued the heart tube looping, suggesting that NFAT may act as 
an upstream regulator of Nkx2.5.  In the next chapter we will present our study on the 
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4.1.   Introduction 
The heart development is initiated during gastrulation when the anterior lateral 
mesoderm becomes specified to a cardiac fate under induction of signals from adjacent 
tissues (Sater and Jacobson, 1989; Schneider and Mercola, 2001; Schultheiss et al., 1995). 
The induction signals in the cardiac initiation stage include BMP family members, FGF 8, 
non-canonical Wnt protein (Wnt 11) and antagonists for canonical Wnt family signaling 
(Eisenberg and Eisenberg, 1999; Pandur et al., 2002; Reifers et al., 2000; Schneider and 
Mercola, 2001; Schultheiss et al., 1997). Upon induction, the cardiac precursor cells 
expressed several key transcription factors, such as Nkx2.5, GATAs and MEF2. These 
genes cooperate with each other to establish a positive cross-regulation network and start 
carcinogenic programme by regulating their down stream cardiac gene expression 
(Harvey, 2002).  
In Drosophila, a homeobox containing transcription factor, tinman, is specifically 
expressed in the dorsal vessel, an insect equivalent of vertebrate heart (Bodmer et al., 
1990). Disruption of tinman gene results in the total deficiency of dorsal vessel (Azpiazu 
and Frasch, 1993; Bodmer, 1993). Nkx2.5 is the veterbarte homolog of Drosophila 
tinman. It is one of the earliest genes expressed in the cardiac precursor cells and it 
expressed through out the developing heart as well as other tissues such as pharyngeal 
arches, spleen, thyroid, stomach and tongue (Komuro and Izumo, 1993; Lints et al., 1993). 
Over-expression of Nkx2.5 in Xenopus results in an enlarged heart and disruption of 
Nkx2.5 causes mouse death in embryonic day 9.5-11.5 due to failure of heart tube looping 
(Cleaver et al., 1996; Lyons et al., 1995; Tanaka et al., 1999a).  Given the role of Nkx2.5 
in early cardiac development, elucidation of the transcriptional regulation of Nkx2.5 will 
help us understanding how cardiac lineage is initiated and maintained. By using Nkx2.5 
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promoter-LacZ transgenic mice, 2 cardiac enhancers, AR1 and AR2, have been identified 
within 9 kb 5’ flanking sequence of Nkx2.5 gene (for review(Schwartz and Olson, 1999). 
Several cardiac  transcription factors bind on the consensus sites of these enhancers and 
regulate Nkx2.5 gene expression including GATA bind transcription factors and BMP 
effectors, Smad proteins (Lien et al., 1999; Lien et al., 2002; Searcy et al., 1998; Shaw et 
al., 1988). These findings partially revealed the regulation mechanism on the transcription 
of Nkx2.5. There are still many questions remaining unsolved in this process. For 
example, both GATA and BMP are expressed more broadly than heart, and there is no 
evidence that GATAs and BMPs expression precede the expression of Nkx2.5 in heart. 
Thus there must be other factors that cooperate with BMP and GATA to regulate Nkx2.5 
expression in heart. 
As transcription factors, NFATs play important roles in cardiovascular 
development. The NFAT activity is controlled by a Ca2+/calmodulin-dependent 
serine/threonine protein phosphatase, calcineurin, which dephosphorylates the cytoplasmic 
NFAT and results in NFAT translocation into the nucleus (Hogan et al., 2003). Upon 
entering the nucleus, NFAT cooperatively bind to DNA with its transcriptional partners 
such as AP1, GATA4 and MEF2 to regulate gene transcription. It has been found that 
NFAT transcriptionaly inhibits VEGF expression and regulate heart valve initiation at E9 
(ref). At E11, NFATc1 directs heart valvular elongation and refinement. NFAT is also 
involves in atrial myocardium development during E14 to P0 through regulate cardiac 
troponins genes expression. NFAT signalling is also needed for the early cardiovascular 
development during mouse embryonic day E7.5-8.5. Inhibition of  NFAT activity by CsA 
during E7.5-8.5 or gene targeted disruption of NFATc3 and NFATc4 in mice causes 
myocardium and vascular deficiency which result in embryonic lethality at E10.5 
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(Bushdid et al., 2003; Graef et al., 2001). However, the molecular processes that are 
involved in NFAT-dependent early cardiogenesis remain to be identified.   
In chapter 3, we have shown that knocking-down GRIM-19 in Xenopus embryos 
compromises both NFAT activity and Nkx2.5 expression from the onset of cardiac 
crescent development. The embryos exhibit cardiac deficiencies during heart tube 
development. Expression of CA- NFATc4 in GRIM-19 KD embryos (GRIM-19 
morphants) rescued the heart defect. This finding raises the possibility that NFAT is 
involved in early cardiogenesis through the regulation of the expression of Nkx2.5. In this 
chapter we will test this hypothesis and study the role of NFAT in Nkx2.5 transcription 
during cardiogenesis.      
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4.2. Results 
4.2.1. Constitutively active NFATc4 rescued Nkx2.5 expression in GRIM-19 KD 
Xenopus embryos. 
Expression of Nkx2.5 was reduced in GRIM-19 morphants (Figure 3.9). To 
examine the effects of NFAT on the Nkx2.5 expression, we first determined if CA-
NFATc4 could restore Nkx2.5 expression in GRIM-19 morphants. GRIM-19 MO1 was 
injected in stage 1 embryos to inhibit GRIM-19 translation. CA-NFATc4 mRNA was then 
injected into two dorsal cells of stage 3 embryos for rescue purpose. Embryos were 
harvested at stage 28, and Nkx2.5 expression was tested by in situ hybridization. As 
shown in Figure 4.1 B, CA-NFATc4 rescued Nkx2.5 expression in GRIM-19 morphants. 
The statistical data (Figure 4.1 A) indicated that 91% of the control embryos expressed 
normal level of Nkx2.5, whereas in GRIM-19 morphants, only 11% expressed Nkx2.5 
normally, and the other 89% embryos displayed either low or no expression. Introducing 
CA-NFATc4 mRNA to the GRIM-19 morphants increased the percentage of normal 
embryos from 11% to 50% and decreased the non-expressing embryos from 33% to 13% 
(P<0.05). Thus NFAT may be an upstream gene that regulates Nkx2.5 gene expression in 
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Figure 4.1 CA-NFATc4 rescues Nkx2.5 expression in XGRIM-19 morphants.  
 
(A) Embryos were injected with control MO, XGRIM-19 MO1 or XGRIM-19 MO1 and 
CA-NFATc4 mRNA as indicated. Nkx2.5 mRNA was detected by in situ hybridization in 
these embryos at stage 28. The percentage of embryos displaying absence (-) of, weak (+) 
or normal (++) Nkx2.5 expression is indicated as bars, and number of the embryos is 
shown on top (n). (**, P<0.01.  *, P<0.05). (B) Ventral view of typical embryos 
hybridized with Nkx2.5 probes. 
 
 
4.2.2. Nkx2.5 gene expression is NFAT dependent during RA-induced cardiac 
differentiation of P19 cells. 
Murine P19 embryonic carcinoma stem cells are capable of differentiating into a 
variety of cell types representative of all three germ layers. Low concentration of retinoic 
acid (RA) induces P19 cells to enter cardiac linage (Edwards and McBurney, 1983). To 
further support the positive effects of NFAT on Nkx2.5 expression in Xenopus, we 
examined NFAT’s role in Nkx2.5 expression in this cell line. Nkx2.5 expression was 
weak in the undifferentiated P19 cells. Low concentration of RA (20 -100 nM) treatment 
significantly induced Nkx2.5 mRNA expression (Figure 4.2 A). However, high-dosage 
Control MO MO1 MO1+CA-NFATc4
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(500-1000nM) RA treatment failed to raise Nkx2.5 expression to similar levels as low 
dosages of RA did, although more cell differentiation was observed in the high dosage 
group (Figure 4.2 A).  The differentiation of P19 cells was indicated by the expression of 
the OCT3 gene, a marker expressed only in the undifferentiated embryonic stem cells 
(Figure 4.2 A). Thus high dosages of RA tend to induce P19 cell differentiation towards 
lineages other than the heart. We also found that induction with 20 nM RA for 3 days 
resulted in maximal Nkx2.5 expression (Figure 4.2 A).  
After 20 nM RA treatment for 3 days, a number of cardiac genes were also 
expressed in P19 cells, including atrial natriuretic factor (ANP), myosin heavy chain 
(MHC) and GATA4, in addition to Nkx2.5 (Figure 4.2 B). 20nM of RA appears sufficient 
to turn on the cardiac programme in mice P19 cells. NFAT family proteins play important 
roles in cardiac development. The mRNA expressions of NFAT c1-4 were also tested in 
P19 cells, before and after RA treatment, by RT-PCR. Results showed that NFAT c1-4 
mRNA were expressed in the undifferentiating P19 cells and remain unchanged after RA 
induction (Figure 4.2 B), which suggests that NFAT may involved in cardiogenesis via 
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Figure 4.2   Low concentration of RA induces Nkx2.5 gene expression and cardiac 
differentiation.  
  
(A) P19 cell were stimulated with indicated concentration of RA for different time.  RNA 
was harvested, and Nkx2.5 expression was checked by RT-PCR. Expression of marker 
OCT3 was examined as a control for cell differentiation, and 18S and 28S RNA are the 
loading controls. (B) P19 cells were treated with 20nM RA or left untreated for 3 days. 
RT-PCR was performed to check the indicated gene expression. 
 
To study the role of NFAT in regulation of Nkx2.5 expression, P19 cells were 
stably transfected with pCDNA3-NFATc4 constructs and control pCDNA3 plasmids. The 
over-expression of NFATc4 mRNA was confirmed by RT-PCR.  The P19 cells which 
over-expressed NFATc4 exhibited higher level of Nkx2.5 expression after induction by 
RA than cells transfected with empty vectors (Figure 4.3A). Thus NFATc4 is able to boost 
Nkx2.5 expression during cardiac differentiation of P19 cells. The NFAT activity was 
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shown that two immuno-repressor drug, FK506 and cyclosporine A (CsA), can inhibit 
calcineurin activity and block its downstream NFAT signaling (Liu et al., 1991). We 
found that in the presence of FK506 and CsA, the RA-induced Nkx2.5 gene expression 
was abolished (Figure 4.3B). This could not have been due to any inhibitory effects of 
FK506 and CsA on cell differentiation, since the expression of OCT3 (octamer binding 
protein 3) underwent similar reductions in  RA-treated cells, regardless of the presence or 
absence of FK506 and CsA. These results suggest that inhibition of calcineurin activity 
may decrease the NFAT transcription activity and the subsequent expression of Nkx2.5. 
Together, these data indicate that expression of active NFAT is required for Nkx2.5 










Figure 4.3 Nkx2.5 gene expression is NFAT dependent.  
(A) Over-expression of NFATc4 increased Nkx2.5 expression induced by RA. P19 cells 
were stably transfected with empty vectors (control) or NFATc4 construct. The Cells were 
stimulated with 20nM RA for 3 days before harvest. NFATc4, Nkx2.5 and OCT3 mRNA 
expression were checked by RT-PCR.   (B) Calcineurin inhibitors FK506 and CsA inhibit 
RA-induced Nkx2.5 expression. P19 cells were stimulated with 20 nM RA in the presence 
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4.2.3. Predicted conserved NFAT and its cofactor binding elements are localized in 
the promoter region of Nkx2.5 genes.  
The mouse Nkx2.5 gene is encoded by two major exons and two small alternative 
exons (exon 1a and 1b) upstream of exon 1(Reecy et al., 1999; Tanaka et al., 1999b). The 
10 kb 5’ flanking sequence of exon 1 contains regulatory elements which direct Nkx2.5 
gene expression in the cardiac crescent and heart tube regions(Lien et al., 1999; Reecy et 
al., 1999; Schwartz and Olson, 1999; Searcy et al., 1998; Tanaka et al., 1999b). Two 
independent cardiac enhancers (red open boxes in Figure 4.4), AR1 minimal cardiac 
enhancer (-9637 to -9125) and AR2 enhancer (-3299 to -2795) have been defined within 
this region (described in detail in section 1.3.1.). Throughout the text, we refer to DNA 







Figure 4.4 Schematic diagram of 10.7 kb 5’-flanking sequence of mouse Nkx2.5 
promoter.  
 
AR1 minimal enhancer and AR2 enhancer are presented by red box. 3 conserved regions 
(CR1-3) among mouse, rat, dog and human are presented by blue boxes. Predicted NFAT 
binding sites (-1176 and -9513) in CR1 and proximal 3 kb of Nkx2.5 promoter are 
indicated by arrows (black arrow: sites able bound by NFAT protein; blue arrow: the site 
unable to be bound by NFAT protein).  The numbers denote the distant of core NFAT 
sites to the start codon of Nkx2.5 gene. * indicates the NFAT sites with transcriptional 
activity. 1a and 1b (black boxes) are two alternative 5’exons. The translation start site is 
marked as +1. 
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By sequence comparison in human, mouse, rat, and dog genes, we found 3 
evolutionarily conserved regions named CR1 (-9679 to -9377), CR2 (-3299 to -2795) and 
CR3 (-2202 to -2009) within this 10 kb promoter, which are shown by blue boxes in 
Figure 4.4. Interestingly, CR2 overlaps with AR2 enhancer, CR1 overlaps partially with 
AR1 by a 260-bp fragment, suggesting that the cis-elements controlling cardiac 
transcription of Nkx2.5 are highly conserved, which agrees with the previous finding by 
(Lien et al. 1999). 
We have found that Nkx2.5 gene expression is under the control of NFAT activity. 
To test if NFAT directly regulates Nkx2.5 expression at the transcriptional level, we 
searched the putative NFAT binding sites in AR1 and 3 kb 5’ flanking sequence of 
Nkx2.5 gene, which includes AR2, with the computer program MatInspector (Genomatix, 
Munich, Germany). Six potential NFAT binding sites containing core sequence 
GGAAA/TTTCC were found in the regulatory region of mouse Nkx2.5 gene and 
designated as -9513, -9460, -3073, -2910, -1910, and -1176 based on their position from 
the translation initiation site of Nkx2.5 gene (shown by arrows in Figure 4.4). NFAT sites 
-9513 and -9460 lie within both AR1 and CR1. Sites -3073 and -2910 are located within 
AR2 , while the other two (sites -1910 and -1176) are located within the 2 kb Nkx2.5 
promoter.  The GGAAA/TTTCC core NFAT binding elements within the AR1/CR1 and 
AR2/CR2 are highly conserved among mouse, rat, dog and human sequences except site -
2910 (Figure 4.5 and Figure 4.6). Interestingly, each conserved NFAT binding site is also 
adjacent to the conserved NFAT co-factor binding sites. NFAT site -9513 was flanked by 
a MEF2 (-9498) and an essential GATA4 (-9570) sites (Figure 4.5). Another GATA (- 
9474) site is adjacent to NFAT site -9460 (Figure 4.5). NFAT site -3073 also was 
localized near two important GATA sites (-3034 and -3022) on AR2 (Figure 4.6).  
                                                                                                                              Chapter 4 



















Figure 4.5 Comparison of the mouse Nkx2.5 CR1 with rat, dog and human sequences. 
Binding sites for NFAT, MEF2 and GATA are boxed up. The essential GATA and NFAT 
sites which exhibit transcription activity are marked with asterisks (*). 
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Figure 4.6 Comparison of the mouse Nkx2.5 CR2 (partial sequence) with rat, dog and 
human sequences. 
Binding sites for NFAT and GATA are boxed up. The essential GATA and NFAT sites 
which exhibit transcription activity are marked with asterisks (*). 
 
4.2.4. NFATc4 interacted with NFAT binding elements in Nkx2.5 gene promoter. 
To study NFAT binding on these potential NFAT sites, we performed 
electrophoretic mobility shift assays (EMSA) using oligonucleotides around 30 base pairs-
long, which contained core NFAT binding sequences as probes. The probes are named 
according to the position of the NFAT sites from the translation starting site. A 27 bp 
sequence from IL-2 promoter containing a canonical NFAT binding site was used as a 
positive control. An NFATc4-DNA complex was detected when the IL-2 probe was 
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incubated with nuclear extracts of HeLa cells transfected with CA-NFATc4, but not under 
incubation with an empty vector (Figure 4.7A).The specificity of the complex was 
confirmed by detection of a super-shift band in the presence of NFATc4, but not in the 
present of an unrelated GP130 antibody. The complex was disrupted by excess amount of 
unlabeled IL-2 probe but not the mutated version. Interestingly, formation of this complex 
was also  inhibited by the addition of  excess amount of cold probes, each containing 
potential NFAT binding sites from mouse Nkx2.5 promoter, except for probe -2910 












Figure 4.7(A-B) NFATc4 interacted with NFAT binding elements in Nkx2.5 gene 
promoter. 
 
(A) EMSA was performed using IL-2 probe and nuclear lysate of HeLa cells transfected 
with CA-NFATc4. The specific binding of NFATc4 and IL-2 probes were demonstrated 
by supershift with NFAT antibody and competition assays by including excess molar 
concentrations of cold IL-2 probe or various probes derived from Nkx2.5 promoter. (B) 
The Interaction of NFATc4 with indicated Nkx2.5 probes. The binding specificity was 
confirmed by super-shifting using NFATc4 antibody. 
Probe      -3073    -2910    -1910   -1176
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Figure 4.7(C-D) NFATc4 interacted with NFAT binding elements in the Nkx2.5 gene 
promoter. 
 
NFATc4 interacts with probe -9513 (C) and -9460 (D).  EMSA was performed using 
indicated probes in presence of indicated antibodies or cold competitors. 
 
 
We further confirmed that all the NFAT binding elements, except for -2910, bound 
to NFATc4 by using them in individual EMSA as probes. As shown in Figure 4.7B, 
probes -3073, -1910 and -1176 but not -2910 formed protein-DNA complexes when 
incubated with nuclear extracts of Hela cells transfected with CA-NFATc4. The specific 
binding of NFATc4 with those probes was further confirmed by formation of supershift 
bands in the presence of the NFATc4 antibody. Besides the above probes containing 
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9460, containing NFAT sites from enhancers AR1 and CB1 were also chosen to study 
their binding capacity with NFATc4.  As shown in Figure 4.7C and D, both probes -9513 
and -9460 bind to NFATc4 protein and form shift complexes. Those shift complexes 
contained NFATc4 as they were super-shifted by NFATc4 but not Gp130 antibody. The 
disruptions of shift complex by IL2 but not IL2 mut probes further confirmed the specific 
binding of probe -9513 and -9460 with NFATc4 protein.  Together, these data indicate 
that NFATc4 protein can specifically bind to the potential NFAT binding sites -9513, -
9460, -3073, -1910 and -1176 but not  -2910 on the Nkx2.5 promoter.   
 
4.2.5. NFATc4 up-regulates Nkx2.5 expression at the transcriptional level. 
We then performed the luciferase report assay to examine whether NFAT regulates 
Nkx2.5 transcriptional activity through these NFAT sites. The CR1 sequence (-9679 to -
9377) was subcloned into PGL3 promoter vector and transfected into p19 cells to analyze 
the enhancers transcriptional activity by luciferase reporter assay (Figure 4.8A). In 
comparison with empty vector, the plasmid containing CR1 increased the reporter gene 
activity 4-fold, which verified that the CR1 sequence acts as an enhancer (Figure 4.8C). 
Interestingly, the 20 nM RA stimulation caused a further increase in transcriptional 
activity of the enhancer plasmids by two (Figure 4.8B). Thus the enhancer may be 
involved in regulating Nkx2.5 gene expression during RA induced cardiac differentiation 
in P19 cells. We found that although co-expression of wild-type NFAT did not 
significantly increase the Nkx2.5 enhancer reporter gene expression in the unstimulated 
cells, the reporter gene expression increased about 2.5-fold after RA treatment. In 
addition, transfection of CA-NFATc4 promoted enhancer reporter gene expression, in the 
absence of stimulation, to levels similar to those obtained when using RA-stimulated wild-
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type NFAT, which was further increased by treatment with RA (Figure 4.8B). Thus, 
NFATc4 is a positive regulator of Nkx2.5 transcription. To elucidate the direct role of 
NFAT in regulating Nkx2.5 transcription, constructs were generated with mutations at 
NFAT binding sites on the Nkx2.5 CR1 enhancer (Figure 4.8A). Although site -9460 
mutation had less effect on enhancer transcription, mutation of site -9513 abolished 
NFATc4-mediated gene transcription significantly (Figure 4.8C). Therefore, NFATc4 
might bind directly to the crucial -9513 site and regulate Nkx2.5 gene expression in vivo. 
Besides, the CR1/AR1 enhancer, we also studied the role of NFAT in regulating 
transcriptional activity of the 3 kb 5’ flanking promoter of Nkx2.5 gene which contains the 
CR2/AR2 enhancer.  The 3 kb promoter was subcloned upstream of a luciferase reporter 
gene (Figure 4.9A). In a similar pattern to that seen with the CR1/AR1 enhancer, the 3 kb 
promoter transcriptional activity was also increased by RA, which provides supports for 
its role in regulating Nkx2.5 expression during heart differentiation. Co-expression of CA-
NFATc4 increased the 3 kb promoter’s transcriptional activity in both uninducted and 
RA-inducted P19 cells (Figure 4.9B) although co-expression of wild-type NFAT had 
hardly any effect on it.  The NFAT dependent transcription activity were abolished upon 
mutation NFAT site -3073 but not sites - 2910, -1910 and -1176.   Thus NFATc4 might 
bind directly on the essential NFAT site -3073 and regulate Nkx2.5 gene transcription in 
vivo. Together, these data suggest that NFATc4 binds to multiple NFAT sites on the 
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Figure 4.8  NFATc4 up-regulates transcriptional activity of Nkx2.5 enhancer.  
 
(A) Nkx2.5 CR1 was subcloned into PGL3 promoter vector containing a basic promoter to 
make the enhancer construct. Sites of mutations at NFAT binding elements in the 
enhancer construct are also shown. (B) Wild-type NFATc4 or constitutively active 
NFATc4 (CA-NFAT4) were cotransfected with Nkx2.5 enhancer luciferase reporter 
constructs into P19 cells. After transfection for 6 h, cells were treated with 20 nM of RA 
or left untreated, cultured for 72 h, and harvested to measure luciferase and renilla activity. 
Three independent experiments were performed and the results are presented. (C) P19 
cells were transfected with wild type or mutated enhancer luciferase reporter constructs 
together with empty vectors or CA-NFATc4 constructs. After transfection for 6h, cells 
were cultured in a media containing 20 nM of RA for 72 h.  Luciferase activity was 
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Figure 4.9  NFATc4 up-regulates transcriptional activity of Nkx2.5 3 kb promoter. 
(A) Proximal 3 kb Nkx2.5 promoter was subcloned into upstream of a luciferase gene. 
Sites of mutations at NFAT binding elements in the 3 kb promoter construct were also 
shown. (B) NFATc4 or CA-NFATc4 was cotransfected with Nkx2.5 3 kb promoter 
luciferase reporter constructs into P19 cells. After transfection for 6 h, cells were treated 
with 20 nM of RA or left untreated, cultured for 72 h, and harvested to measure luciferase 
and renilla activity, as were those shown in Figure 4.8. (C) P19 cells were transfected with 
wild type and mutated 3 kb promoter luciferase reporter constructs together with empty 
vectors or CA-NFATc4 constructs. Cells were treated with RA and luciferase activity was 
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The transcription factor NFAT is important in both cardiac hypertrophy and 
embryonic heart development. Although the calcium-calcineurin-NFAT pathway in the 
regulation of cardiac hypertrophy is well documented (Blaeser et al., 2000; Molkentin et 
al., 1998), NFAT’s function in early cardiac development is largely unknown.  NFAT 
reportedly plays a role in regulating transcription of myocardial genes cTnl and cTnT 
between mouse embryonic days E14 and P0 (Schubert et al., 2003). However, double 
knockout NFATc3 and NFATc4 in mice resulted in defective cardiac development and 
embryonic death at around E10.5 (Bushdid et al., 2003), a critical time point when cardiac 
function is necessary for proper embryonic development in mice. Disruption of a number 
of genes which are involved in early cardiogenesis including Nkx2.5, Hand2 and  MEF2C, 
is known to  result in embryonic lethality at this stage (Lin et al., 1997; Lyons et al., 1995; 
Tanaka et al., 1999a; Srivastava et al., 1997). Thus, besides cTnl and cTnT, NFAT must 
regulate other genes which are involved in early cardiac development.  In this study, we 
demonstrate that NFAT regulate Nkx2.5 gene expression and plays a crucial role in heart 
development.    
Nkx2.5 is one of the first genes to be expressed specifically in the heart formation 
region of vertebrate embryos (Komuro and Izumo, 1993; Lints et al., 1993). Disruption of 
the  Nkx2.5 gene in mice causes failure in heart tube looping, the same phenotype in 
GRIM-19 KD Xenopus embryos (Lyons et al., 1995; Tanaka et al., 1999a). In chapter 2, 
we have demonstrated that disruption of GRIM-19 results in compromised calcium-
calcineurin-NFAT pathway and heart developmental defect in Xenopus embryos. 
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Strikingly, a decrease Nkx2.5 gene expression was also observed in GRIM-19 morphants. 
The Nkx2.5 deficiency was partially rescued by injection of constitutively active NFATc4 
in GRIM-19 morphants, which suggests that NFAT is an upstream signal of the Nkx2.5 
gene. In this study, we also tested this hypothesis in P19 cells. Low concentrations of RA 
induce cardiac differentiation and Nkx2.5 gene expression in P19 cells. This RA-induced 
Nkx2.5 expression can be boosted by overexpression of NFATc4, and suppressed by 
calcineurin inhibitors FK506 and CsA. Thus, NFAT is able to regulate Nkx2.5 gene 
expression during cardiac differentiation.  
Nkx2.5 gene expression is controlled by multiple positive and negative regulatory 
elements distributed in both 5’ and 3’ flanking regions of the gene. Among those cis-
acting regulatory elements, 2 conserved enhancers, CR1/AR1 and CR2/AR2, are 
important in directing gene expression in the heart.  Both AR1 and AR2 contain high-
affinity binding sites for multiple cardiogenesis transcription factors, including members 
of the GATA family of zinc finger proteins (Lien et al., 1999; Searcy et al., 1998). In 
CR1/AR1, the GATA site at -9570  is required for the enhancer activity in cardiac 
development (Lien et al., 2002). The two GATA sites at -3034  and -3022   are also crucial 
for cardiac transcriptional activity of AR2 (Searcy et al., 1998). Although the three GATA 
proteins, GATA4, GATA5 and GATA6, are expressed in the developing heart in patterns 
overlapping with that of Nkx2.5, the GATAs are also expressed in other regions of the 
embryo where Nkx2.5 expression has been inactivated, for example the endodermally 
derived region of the gut (Morrisey et al., 1996; Morrisey et al., 1997). Thus, GATA 
factors must couple to other factors associated with the cardiac regions, to activate 
transcription of Nkx2.5.      
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One of the co-factors could be NFAT. In this report we demonstrated that NFAT 
can directly activate Nkx2.5 transcription through binding of conserved NFAT sites on the 
Nkx2.5 enhancer. We found that both CR1/AR1 and CR2/AR2 transcriptional activity are 
NFAT dependent. There are four putative NFAT binding sites localized in CR1/AR1 and 
CR2/AR2 enhancers. Although EMSA shows that three sites, -9513, -9460 and -3073, 
bind specifically to NFATc4 protein in vitro, only -9513 and -3073 are essential for 
NFATc4-dependent transcription of the enhancer CR1/AR1 and CR2/AR2 respectively. 
Thus the transcription activities of NFAT sites are not absolutely dependent on binding by 
NFAT protein alone. Indeed, it has been shown that for maximal its transcriptional 
activity, binding high affinity with NFAT recognition site, cooperation between NFAT 
and its partner is necessary. The NFAT partners include AP1, C/EBP, GATA and MEF2 
(Hogan et al., 2003). Cooperation of NFAT and AP1 is crucial for expression of many 
cytokine genes in immune system cells (Macian et al., 2001), while interaction of NFAT 
with GATA is essential for regulation of cardiac gene expression such as b type natriuretic 
peptide (BNP) (Molkentin et al., 1998).  Interestingly, the essential GATA site -9570 is 
adjacent to the NFAT site -9513 on CR1/AR1.   NFAT site -3073 is also flanked by the 
two essential GATA sites (-3034 and -3022) on CR2/AR2. This finding raises the 
possibility that NFAT works in combination with GATA factors to regulate Nkx2.5 gene 
expression. Besides GATA sites, there is a putative MEF site located 11 bp away from 
NFAT site -9513 on CR1/AR1.  In addition to GATA protein, the MADS-box 
transcription factor MEF2 also interacts with NFAT to mediate gene expression in the 
event of an immunoresponse, and for the control  skeletal muscle fiber type (Blaeser et al., 
2000). MEF2C is also important for myocardium gene expression and development 
(Kuisk et al., 1996; Lin et al., 1997; Ross et al., 1996). Thus, NFAT may form a 
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distinctive composite enhancer complex with different NFAT partners such as GATA and 
MEF to mediate Nkx2.5 gene transcription.  The NFAT, GATA and MEF sites in Nkx2.5 
enhancers are highly conserved among mammals which reflects on the evolutionally 
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5.1. GRM-19 knocking-down Xenopus as a model for studying the MRC functions in 
early embryonic development.  
This study investigated the role of MRC in embryonic especially cardiac 
development and the underlying calcium-dependent NFAT signaling involved in this 
process. First, we generated a MRC defect animal model by knocking down GRIM-19 in 
Xenopus embryos. Disruption of GRIM-19 in Xenopus embryos caused typical multi-
system syndromes of mitochondria diseases including growth retardant, encephalopathy, 
ophthalmologic disorder, myopathy and cardiomyopathy. Therefore, knocking down the 
nuclear encoded MRC protein GRIM-19 in Xenopus embryos can be potentially utilized 
as an animal model for mitochondrial diseases caused by MRC deficiency. 
Severe MRC deficiencies also interfere with embryo development. However, the 
abnormalities of organs (especially heart) development usually result in embryonic 
lethality and can hardly be studied in mammalian system. The externally developmental 
Xenopus embryos provide a useful model in studying the embryonic abnormalities caused 
by MRC defect. In this study, we found that knocking down GRIM-19 resulted in a 
deficiency in heart development in Xenopus, which is consistent with the finding in 
TFAM knockout mice. The heart tubes form normally but failed in looping in the GRIM-
19 KD embryos. This phenotype mimics the heart defect in Nkx2.5 knockout mice. Indeed 
the expression of both Nkx2.5 and it downstream regulated genes such as MLC2 and 
cardiac actin decreased in GRIM-19 KD embryos, suggesting that MRC play a role in 
Nkx2.5 signaling. Other important cardiac induction signals such as BMP4 and GATA4 
are expressed normally in cardiac region of GRIM-19 defect embryos, which exclude the 
general effect of MRC deficiency on gene transcription.   
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5.2. MRC activity is crucial for triggering intracellular calcium mobilization and 
NFAT activity. 
Mitochondria can regulate specific signal pathways through retrograde 
communication. During this process, changes in the functional states of mitochondria 
affect the metabolic cues or intracellular calcium dynamics, which in turn culminate in 
changes in nuclear gene expression. The role of mitochondria in calcium mobilization has 
been studied. However, most studies focused on the role of mitochondria as a buffering 
system that can rapidly take up and slowly release large amounts of Ca2+ to protect cells 
against cytosolic Ca2+ overloading under pathophysiological conditions (Duchen, 2000). 
The role of MRC on calcium signalling is largely unknown. Recently, the studies using 
MRC inhibitors showed that  disruption of MRC activity impaired calcium homeostasis 
and oscillation in fertilizing eggs (Liu et al., 2001; Dumollard et al., 2004). Thus, MRC 
function may be crucial for activation of intracellular calcium signalling. Since chemical 
MRC inhibitors may cause non-specific effect on intracellular calcium signalling, a gene 
targeted study is needed to demonstrate the role of the MRC in the Ca2+ regulation. In this 
study, we specifically disrupted the expression of two mitochondrial complex I subunits, 
GRIM-19 and NDUFS3, in HeLa and Jurkat cells by siRNA. Disruption of both GRIM-19 
and NDUFS3 in HeLa cells resulted in impairment of intracellular calcium release and 
consequent CRAC. Triggering of CRAC is essential for activation of NFAT. Indeed, the 
endogenous NFAT activity was compromised in Jurkat cells with   GRIM-19 or NDUFS3 
deficiency. Thus, our study verify the crucial role of MRC on the calcium dynamics on 
protein level, and  reveal a novel NFAT pathway which is under control of  MRC.  How 
MRC regulates calcium dynamic still remains elusive. It has been found  that 
mitochondrial calcium buffering help to prolong  Ca2+ release-activated Ca2+ current 
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(ICRAC) through inhibition of Ca2+ dependent slow inactivation of Ca2+ influx (Parekh, 
2003).  However, our study showed that the intracellular calcium release was 
compromised before it can trigger CRAC in MRC defective cells. Thus, MRC may 
regulate calcium dynamic mainly through modulation of the intracellular calcium release 
from the ER. To our knowledge, MRC may be involved in this process through two ways. 
Firstly, ATP production by mitochondrial MRC increases the storage of calcium in the ER 
via Ca2+ ATPases (SERCA). Secondly, ATP may also regulate the sensitivity of InsP3 
receptors on ER (Bezprozvanny and Ehrlich, 1993).  Disruption of MRC activity could 
lead to a low ER calcium pool and cause insensitivity of InsP3 receptors, which results in 
failure of intracellular calcium release. Future works are needed to test these hypothesis.  
 
5.3. NFAT is a transcriptional regulator of Nkx2.5. 
NFAT is involved in cardiac development. Indeed, we found that NFAT signaling 
is impaired in GRIM-19 KD embryos, and CA-NFATc4 can rescue the heart defect in 
these embryos. More interestingly, CA-NFATc4 also rescued the Nkx2.5 gene expression. 
This finding reveals an unknown link between these two important cardiac transcriptional 
factors. In Chapter 4 we studied the regulation mechanism of Nkx2.5 by NFAT. We found 
that NFAT directly bound on the Nkx2.5 promoter and regulated Nkx2.5 transcription. To 
our best knowledge, this is the first evidence showing that Nkx2.5 is under direct control 
of NFAT genes. This finding reveals an unknown mechanism of NFAT in regulating early 
cardiac development, and also expands our understanding on Nkx2.5 transcription. The 
Nkx2.5 transcription is among the first step of cardiac differentiation and need the 
cooperation of multiple transcriptional factors. It has been found that cardiac induction 
signals trigger transcription factors such as smad and GATA proteins which binds on the 
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Nkx2.5 promoter and regulates Nkx2.5 transcription. Our finding adds the NFAT as 
another crucial transactional factor which is involved in this complex regulatory process. 
The GATA binding site is close to the NFAT binding sites on Nkx2.5 promoter, which 
suggests that NFAT may synergistically cooperate with GATA factors in regulating 
Nkx2.5 gene expression. Indeed, NFAT has been shown to interact with GATA4 to 
regulate a number of gene expression including cardiac gene BNP (Molkentin et al., 
1998). It is worth to conduct the study to test the synergistic effect of NFAT and GATA 
proteins on the Nkx2.5 transcription in future.  
 
5.4. A model of regulation of heart development by MRC. 
Based on the current data, we propose a model for the role of the MRC in heart 
development (Figure 5.1). The cardiac development is initiated at late gastrulation when 
various cardiac induction signals trigger the cardiac precursor cells to express the cardiac 
key transcriptional factors including Nkx2.5 which turn on the cardiac programme. Some 
cardiac induction signals may trigger intracellular calcium release and subsequent CRAC 
which activate NFAT proteins. NFAT cooperates with other transcriptional factors such as 
GATA to bind on the promoter of Nkx2.5 and regulate Nkx2.5 gene expression. 
Mitochondrial MRC plays a crucial role in cardiogenesis through the regulation of 
cytosolic calcium signals and the subsequent calcium-dependent NFAT pathway. This 
could be achieved by modulation of the intracellular calcium release from the ER. ATP 
production by mitochondrial MRC could help to increase the ER calcium storage and 
maintain the sensitivity of InsP3 receptors on ER (Bezprozvanny and Ehrlich, 1993). 
Conversely, calcium release from ER leads to higher calcium level in mitochondria, 
stimulating the Krebs cycle and MRC enzymatic activity and augmenting ATP production 
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(McCormack and Denton, 1993). MRC dysfunction perturbs the Ca2+ dynamics, which 










Figure 5.1  A model of regulation of heart development by MRC. 
 
In a summary, our study revealed an important role of MRC in heart development 
via a calcium-dependent NFAT signaling pathway. We also found that NFAT functions in 
early cardiogensis through the regulation of Nkx2.5 expression. It still remains elusive as 
to which cardiac induction signals could trigger the activation of NFAT during early 
cardiogenesis.  One of the potential upstream signal could be non-canonical Wnt proteins.  
non-canonical Wnt proteins are among the molecular pathways that lead to active 
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activating NFAT and promoting ventral cell fate in Xenopus (Saneyoshi et al., 2002; 
Schroeder et al., 1999). Wnt11, a  member of  non-canonical Wnt family proteins, is 
enriched in precardiac mesoderm in both mouse and avian embryo (Eisenberg et al., 1997; 
Eisenberg and Eisenberg, 1999; Kispert et al., 1996). Disruption of Wnt11 impaired 
Nkx2.5 expression and cardiac development (Pandur et al., 2002) although the mechanism 
underlying this process is still not clear.  It would be interesting to test if Wnt11 works as 
an upstream regulator of NFAT, therefore, activate Nkx2.5 expression upon initiation of 
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